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General introduction
backgrounD
Dementia is a syndrome characterized by deterioration in memory, thinking and the ability 
to perform everyday activities. Worldwide, around 50 million people have dementia, and 
there are nearly 10 million new cases every year.1 Dementia has a physical, psychological and 
social impact on people with dementia, their family members, their caregivers and on society 
as a whole.1 Many people with dementia live in the community and are cared for by their 
general practitioner (GP). During the course of dementia most people develop some type of 
behavioural symptoms, also called neuropsychiatric symptoms (NPS). These NPS affect their 
quality of life and their relation with their (informal) caregivers negatively.2,3 Psychotropic 
drugs are often prescribed in this process. GPs have an important role in diagnosing and 
managing NPS. In the following, each of these elements are introduced in more detail.
occurrence of Dementia anD transition of Dementia care
In the Netherlands, it is estimated that there are 254.000 to 270.000 people with dementia 
of whom approximately 70 % are community-dwelling, that is not institutionalized in long-
term care facilities (LTCF).4,5 Sixty percent of the community-dwelling people with dementia 
live with their informal caregiver and 40 % alone.6 The prevalence rate of dementia in an 
average general practice of 2095 patients is 36 (2 %).7 In the last few years, due to the prefer-
ence of older people to remain in their own home, the high healthcare costs associated with 
living in LTCF and the government policy, the number of people with dementia living in their 
own homes increases. The governments’ motto is “At home as long as possible”. In 2015, 
a new Long-term Care Act (Wet langdurige zorg) was introduced in the Netherlands, that 
replaced the Exceptional Medical Expenses Act (Algemene Wet Bijzondere Ziektekosten). 
The objective of this new act was to safeguard the financial sustainability of long-term care 
and to improve the quality of it by making it more client-tailored.8 People with dementia 
living at home and their informal caregivers, on the other hand, now have to deal with 3 
different legal frameworks for the organization and financing of their dementia care during 
the trajectory of the disease i.e.: Social Support Act (Wet maatschappelijke ondersteuning) 
run by municipalities, Health Insurance Act (Zorgverzekeringswet) and the Long-term Care 
Act.5,8 This has a considerable impact on the structure and level of health care for both the 
person with dementia and their informal caregivers as well as on professional caregivers 
and the medical care provided by the GP.5 For dementia care in primary care, a joint venture 
between GP, dementia case manager and elderly care physicians is recommended.7,9,10
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role of the general practitioner
GPs play a pivotal role in the care of people with dementia and their family members. The 
GP is most often the first physician consulted for dementia-related problems. Many GPs 
are aware of the additional workload attached to caring for dementia patients in their daily 
practice. On the other hand, dementia is still under-detected in primary care. Approximately 
40 to 45 % people with dementia are not registered with a diagnosis of dementia in the 
electronic medical records of the GP.11,12 Moreover, GPs find making the diagnosis, disclosing 
the diagnosis and the management of dementia and particularly NPS difficult.13-15 This is a 
consequence of limited confidence in their diagnostic skills, reluctance in disclosing the diag-
nosis and lack of knowledge in the management of NPS and other problems in dementia.14,15 
Moreover, the care provided to people with dementia and NPS is often reactive. Repeated 
phone calls as signs of a deteriorating situation or mismatch of expectations of the family and 
the capabilities of the GP concerning people with dementia have a high impact on GPs.13-15
According to the Dutch GP guideline for Dementia, problem behaviour is defined as all 
behaviour of the patient that is perceived as difficult to manage by the patient themselves or 
his/her environment.7 The guideline mentions as examples: agitation or aggression, apathy, 
diminished empathy, rejecting any assistance, reversion of day en night rythm, incompas-
sionate excessive crying or laughing, disinhibition with food or sexual disinhibition, physical 
hyperactivity, wandering, compulsive hoarding, hiding things and loss of appropriateness.7 
The guideline provides management strategies for non-pharmacological and pharmaco-
logical interventions in case NPS occur in people with dementia. In the guideline there is no 
recommendation for actively identifying problem behaviour in patients with dementia and 
for psychological distress by their informal caregivers by the GP.7
Development of neuropsychiatric symptoms
Human behaviour is the result of a complex interaction of biological, psychological and 
social factors in the context of the environment (biopsychosocial model).16 This complex 
model also applies to the behaviour of people with dementia. The behaviour of people with 
dementia is not only dependent on changes in brain function, but also on how that impacts 
their perception, coping and ability for response control.17 The determining factor for con-
sidering (changes in) behaviour of people with dementia as problem behaviour is not the 
behaviour itself, but how behaviour is perceived by others.18 In this thesis we used the term 
NPS instead of problem behaviour, since our research was carried out from a doctor-patient 
relationship, focusing on generating information for GPs.
During the course of dementia most people develop some type of NPS.19-25 NPS include 
psychiatric and behavioural symptoms. The Neuropsychiatric Inventory (NPI), for example, 
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is a widely-used rating scale assessing 12 different NPS: delusions, hallucinations, agitation/
aggression, depression, anxiety, euphoria, apathy, disinhibition, irritability, aberrant motor 
behaviour, nighttime behaviour disturbances and eating changes. 26-28 Based on the NPI, 
NPS can be categorized in subsyndromes: mood/apathy, hyperactivity and psychosis.29,30 
The prevalence and incidence rates of NPS measured with the NPI in community-dwelling 
people with dementia are high and moreover NPS are persistent although frequency pa-
rameters vary considerably across studies.19,21,25,31,32 apathy, depression, aberrant motor 
behaviour, agitation, irritability and sleep disturbance are the most common individual NPS 
among people with dementia.19,21 For hallucinations, delusions, agitation, aberrant motor 
behaviour, disinhibition, apathy, and sleep disturbance increasing trends in point prevalence 
rates during the course of the disease have been found.19,21,25,31 The mood/apathy and the 
hyperactivity subsyndrome are the most common NPI subsyndromes .19,21
impact of neuropsychiatric symptoms
NPS in general and depression in particular, are predictors of institutionalization.33,34 They 
are also associated with psychological distress among informal caregivers.35-37 NPS result in a 
lower quality of life for both people with dementia and their caregivers and negatively affect 
the quality of the patient-caregiver relationship.2,3 Greater cognitive impairment, higher 
baseline severity of NPS and increased functional impairment lead to more NPS.30,38-42 The 
use of support services, like day and respite care and training courses for caregivers, are 
associated with less NPS over time.38
Informal caregivers of people with dementia experience psychological distress including 
feelings of burden and depressive and anxiety symptoms and disorders. Therefore, they are 
at risk for a deteriorating mental health.43,44 In cross-sectional studies, caregiver characteris-
tics associated with more psychological distress are: (younger) age, (female) gender, (lower) 
educational level/socioeconomic status, longer duration of caregiving and caregiver-patient 
relationship.45,46 Patient characteristics that are associated with increasing psychological 
distress in informal caregivers over time are: higher frequency of NPS, deterioration of 
dementia and decline in activities of daily living (ADL) of the patient. High baseline burden, 
living with the patient, and poor mental health of the caregiver are caregiver characteristics 
that are associated with increasing psychological distress over time. NPS are the most signifi-
cant contributors to the course of psychological distress in the informal caregivers.32,37,47-52 
Although depression, aggression, and sleep disturbances are the most frequently identified 
NPS to impact negatively on caregivers, a wide range of NPS is associated with psychological 
distress. However, the evidence is not conclusive as to whether some NPS are more impor-
tant than others.53
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use of psychotropic Drugs
The GP has an important role in prescribing psychotropic drugs.13,54 Practice guidelines for 
NPS recommend non-pharmacological management as first-line treatment and these pre-
dominantly psychosocial interventions may lead to a substantial reduction of antipsychotic 
drug prescription.55,56 However, psychotropic drugs, such as antipsychotics and antidepres-
sants, are frequently prescribed to patients with dementia with agitation, psychosis and 
anxiety. The prevalence of psychotropic drug use is related to the presence of NPS.11,54 There 
is only limited evidence for the effectiveness of psychotropic drugs in the treatment of NPS 
in people with dementia. Moreover, they cause serious adverse effects, such as extrapyrami-
dal, anticholinergic and cardiovascular symptoms and increase of NPS.57-59
What is knoWn about neuropsychiatric symptoms in primary care?
Almost all studies on the course of NPS in community-dwelling people with dementia were 
conducted in ambulatory patients with dementia visiting outpatients’ memory, (old-age) 
psychiatry, neurological or geriatric clinical centres or dementia services. In these studies, 
most participants were living at home, but still part of them were living in LTCF or it was 
not clear what part of the study population was institutionalized.19-23,25,31,32,39-41,60,61 In the 
Netherlands, GPs provide basic medical care for people who live at home. For LTCF there are 
specifically trained medical doctors called elderly care physicians.62 Only a limited proportion 
of people in general practice in the Netherlands are referred to secondary care. Therefore, 
it is likely that a study population visiting outpatient clinical centres has more severe and 
frequent symptoms than the total group of people with dementia in general practice.
aim of this thesis
So far, prospective studies on the course of NPS have not been conducted in patients 
exclusively from general practices. For GPs, it is important that accurate data of NPS and 
psychotropic drug use of patients with dementia in general practices are available. There-
fore, the general aim of this thesis is to investigate the prevalence of NPS and psychotropic 
drug use, as well as the course and determinants of NPS in people with dementia and the 
psychological distress in their informal caregivers in primary care.
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The following research questions are addressed:
1. What is known from previous research about the prevalence and course of NPS in 
community-dwelling people with dementia? (chapter 3)
2. What is the prevalence of NPS and psychotropic drug use in people with dementia in 
general practice? (chapter 4)
3. What is the course of NPS and which are the determinants for the course of NPS in 
people with dementia in primary care? (chapter 5)
4. What is the course of and which are the determinants of psychological distress in 
informal caregivers of people with dementia in primary care? (chapter 6)
outline of this thesis
The study protocol of this study is described in chapter 2.
In chapter 3 the existing literature is systematically reviewed to know the prevalence and 
course of NPS in community-dwelling people with dementia.
In chapter 4 the prevalence of NPS and the prevalence of psychotropic drug use are assessed 
in patients with dementia in general practice
In chapter 5 the course of NPS in patients with dementia in primary care is investigated and 
determinants for the course of NPS in people with dementia in primary care were detected.
In chapter 6 the course and determinants of psychological distress in informal caregivers of 
people with dementia in primary care are investigated.
In chapter 7 the main findings of this study are summarized and discussed together with 
methodological considerations. In addition, the impact for dementia care and manage-
ment in general practices and implications and recommendations for future education and 
research are addressed.
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abstract
background
Neuropsychiatric symptoms (NPS) frequently occur in patients with dementia. To date, 
prospective studies on the course of NPS have been conducted in patients with dementia 
in clinical centres or psychiatric services. The primary goal of this study is to investigate the 
course of NPS in patients with dementia and caregiver distress in primary care. We also aim 
to detect determinants of both the course of NPS in patients with dementia and informal 
caregiver distress in primary care.
methods/design
This is a prospective observational study on the course of NPS in patients with dementia in 
primary care. Thirty-seven general practitioners (GPs) in 18 general practices were selected 
based on their interest in participating in this study. We will retrieve electronic medical 
files of patients with dementia from these general practices. Patients and caregivers will 
be followed for 18 months during the period January 2012 to December 2013. Patient 
characteristics will be collected at baseline. Time to death or institutionalization will be 
measured. Co-morbidity will be assessed using the Charlson index. Psychotropic drug use 
and primary and secondary outcome measures will be measured at 3 assessments, baseline, 
9 and 18 months. The primary outcome measures are the Neuropsychiatric Inventory score 
for patients with dementia and the Sense of Competence score for informal caregivers. In 
addition to descriptive analyses frequency parameters will be computed. Univariate analysis 
will be performed to identify determinants of the course of NPS and informal caregiver dis-
tress. All determinants will then be tested in a multivariate regression analysis to determine 
their unique contribution to the course of NPS and caregiver distress.
Discussion
The results of this study will provide data on the course of NPS, which is clinically important 
for prognosis. The data will help GPs and other professionals in planning follow-up visits and 
in the timing for offering psycho-education, psychosocial interventions and the provision 
of care. In addition, these data will enlarge health professionals’ awareness of NPS in their 
patients with dementia.
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backgrounD
Dementia is a chronic and mostly progressive disease with great impact on patients and their 
family members. Current estimates indicate that 35.6 million people worldwide are living 
with dementia. This number is expected to double by 2030 and more than triple by 2050.1 
The estimated standardized prevalence of dementia among persons aged 60 and over in 
Western Europe, Central Europe and Eastern Europe is 7.3 %, 5.8 % and 5.7 %, respectively.1 
In the Netherlands 250,000 people have dementia, and most of these patients reside in the 
community.
Neuropsychiatric symptoms (NPS), such as psychosis (delusions and hallucinations), 
depressive mood, anxiety, irritability/lability, apathy, euphoria, disinhibition, agitation/
aggression, aberrant motor activity, sleep disturbance and eating disorder, often occur in 
patients with dementia. NPS result in lower quality of life for both the patient and care-
giver and affect the quality of the patient-caregiver relationship.2,3 NPS, severity of cognitive 
impairment, Alzheimer’s dementia, high rates of functional dependence and depressive 
symptoms are predictors of nursing home admission.4 Major depression is a predictor of 
early institutionalization in the first year following the dementia diagnosis.5 The baseline 
severity of NPS, stage of dementia and use of support services predict the future severity 
of NPS.6 However, there is a lack of knowledge about the determinants of neuropsychiatric 
symptoms in community-dwelling patients with dementia.
Studies in various countries reported NPS prevalence rates that ranged from 66 to 94 %.7-13 
Incidence rates of NPS were reported in only a few studies. In a United States of America 
(USA) Cache County study, Steinberg et al. found an incidence rate of 69 % after an 18-month 
follow-up.14 Only one Dutch study has been conducted on the course of NPS in community-
dwelling people with dementia. In the MAASBED (MAAstricht Study of BEhaviour in Demen-
tia) study it was found that 81 % of the patients with dementia from a memory clinic and 
an ambulatory mental health institute showed any type of NPS, such as agitation (19 %), 
irritability (24 %), aberrant motor behaviour (26 %), depression (35 %), apathy (40 %), anxiety 
(21 %) and delusions (22 %).15 After a 6 - 12-month follow-up, the cumulative incidence of 
NPS was 74 %.15 Several prospective studies of NPS in community-dwelling patients with 
dementia have been conducted in other countries. In most of these studies, the Neuropsy-
chiatric Inventory (NPI) was used to evaluate NPS. Eighty-one percent of those without any 
NPS at baseline had at least one symptom after 18 months in the USA Cache County study.16 
In the same study, 67 % of the participants with at least 1 clinically significant NPS (total NPI 
score ≥ 4) at baseline continued to display clinically significant NPS after 18 months. Among 
the 10 neuropsychiatric symptoms assessed at baseline, delusions persisted in 66 %, depres-
sion in 58 % and aberrant motor behaviour in 56 % of the individuals. Hallucinations and 
disinhibition persisted in 25 % and 11 % of the participants, respectively.16 In a study in the 
United Kingdom, 94 % of the participants had at least one NPS and 75 % of the participants 
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had an NPI score ≥ 4 for at least one symptom. Of the latter group, 80 % had a persistent NPI 
score ≥ 4 in at least one domain after 6 months.12 Furthermore, a 2-year follow-up study in 
England and Wales showed that NPS co-occur.17 anxiety and depression as well as misiden-
tification, persecution and hallucinations were strongly associated.17 The REAL-FR (Réseau 
sur la Maladie d’ Alzheimer Français) cohort study found that the percentage of patients 
presenting one or more clinically relevant NPS as measured by the NPI increased from 66 % 
at baseline to 88 % after 4-year follow-up.13 Prevalence of agitation increased from 17.9 % to 
29.1 %, apathy from 43.0 % to 62.9 %, disinhibition from 2.6 % to 14.6 %, hallucinations from 
2 % to 4.6 % and aberrant motor behaviour from 13.9 % to 29.1 %. Prevalence of hyperactivity 
and apathy increased significantly during the follow-up, whereas the prevalence of affective 
and psychotic symptoms did not increase.13
To date, prospective studies on the course of NPS have been conducted on ambulatory 
patients with dementia in memory clinics or clinical centres13,15, using ambulatory services15 
or who were approached through local psychiatric services, the volunteer sector and nursing 
and residential care homes.12 High (cumulative) prevalence and (cumulative) incidence rates 
of NPS were found in these studies. In the REAL-FR cohort, a prevalence of 66 % at baseline 
increased to 88 % after 4 years.13 In the MAASBED study, a prevalence of 80.9 % at baseline 
increased to a cumulative prevalence of 88.9 % after 2 years, and the cumulative incidence 
after 6 - 12 months was 74 % in ambulatory patients of memory clinics or psychiatric ser-
vices.15 In the LASER-AD (London And the South East Region - Alzheimer’s Disease) study, 
33 % of the participants were recruited from 24-hour care settings and 67 % were living at 
home. The prevalence rates of NPS at baseline were 93.8 % for at least one NPS, and 88.4 % 
of the participants had a NPI score ≥ 4 in at least one domain. At 6-month follow-up, 96.2 % 
had at least one NPS in any domain. Of these participants 80.3 % had a persistent NPI score 
≥ 4 in at least one domain.12
Steinberg and Savva have studied a community-dwelling population.16,17 In Cache County, 
62 % of the participants with dementia had at least one NPS at baseline and 23 % had a 
NPI score ≥ 4 in at least one domain. After 18 months, 95 % of the participants had at least 
one NPS at baseline and 49 % had a NPI score ≥ 4 in at least one domain. However, of the 
5092 individuals who were enrolled in this study, 265 resided in nursing homes. Information 
was not provided on the percentage of the 329 participants with dementia who resided in 
nursing homes.16 In the Medical Research Council Cognitive Function and Aging Study, preva-
lence rates of 5.8 % for confabulation to 50.3 % for apathy were found in dementia patients. 
Incidence rates of 2 % for anxiety to 61 % for apathy were found after 2 years. Furthermore, 
persistence rates were 13 % for confabulation and 66 % for apathy. The percentage of partici-
pants who lived in institutions was 38 % at baseline and 66 % after 2-year follow-up.
It appears as though the prevalence and incidence rates of NPS in community-dwelling 
patients with dementia are lower (23 % to 50 % and 49 % to 60 % respectively) than those 
of ambulatory patients of memory clinics or clinical centres and ambulatory patients of 
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psychiatric services (66 % to 96.2 % and 74 % respectively). Finally, the relationship between 
caregiver characteristics and caregiver distress and NPS was unclear in these studies.
aims of the study
The first aim of this study is to investigate the course of NPS in patients with dementia and 
informal caregiver distress in primary care. We also aim to detect determinants of both the 
course of NPS in patients with dementia and informal caregiver distress in primary care.
methoDs/Design
study design
This is a prospective observational cohort study in primary care. For this study, all 192 known 
general practitioners (GPs) in 114 general practices in the region West- and Middle-Brabant 
in the southern part of the Netherlands were invited to participate. All GPs of the 114 prac-
tices individually received a letter with information on the study and were invited to attend 
a meeting about NPS and the study. Announcements of this study were also posted on the 
websites of the regional GP corporations. Thirty-seven GPs in 18 general practices were 
selected based on their interest in participating in the study. The presence of specialized care 
for elderly people in the general practices will be determined by asking whether the partici-
pating GPs followed a specialized management training course in elderly care medicine in 
primary care and whether specialized staff members are available in these general practices 
to support the GP in managing the care for elderly patients. We will retrieve electronic 
medical files of patients with dementia from these general practices. Patients and informal 
caregivers will be approached by letter. Informal caregivers are persons who are listed in the 
electronic medical files of the GP as the main informal caregiver and contact person. There 
will be no restriction in the amount of time that the informal caregiver spends with the 
patient. After the letter is mailed to the patient and informal caregiver, the GP will contact 
the patient or informal caregiver by telephone to stimulate participation in the study. The 
assessment interviews will take place at the patients’ home by a trained interviewer.
Patients and informal caregivers will be followed for 18 months. In case that a patient dies 
or will be institutionalized, length of time to death or institutionalization, respectively, will be 
measured. The study began in January 2012 and will end in December 2013.
In the Netherlands, many psychosocial interventions and care services are available for 
community-dwelling people with dementia, including cognitive training and stimulation, 
physical exercise, reminiscence, education and support for both patient and informal care-
giver and respite care. Dementia case management is stimulated by the Dutch government 
and is available in all parts of the country. Dementia case management involves assessment, 
planning and advocacy for patients with dementia and their informal caregivers. It also aims 
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to empower informal caregivers and facilitate timely access to essential care services to 
support their caregiver needs. In the southern region of the Netherlands, a dementia case 
manager (CM) is provided by many care organizations and care services. We consider this 
single component dementia case management.
In 14 of the participating general practices, a multicomponent collaborative care pro-
gram named CONCERN (Care Optimization for Non-professional Caregivers of Elderly with 
dementia and Reduction of Neuropsychiatric symptoms) will be provided. In CONCERN, 
a dementia CM together with an elderly care physician and the GP focus on optimization 
of care and improvement of quality of life for patients with dementia suffering from NPS 
and their informal caregivers. Following assessment and diagnosis of the NPS, a care plan 
is designed for the treatment and support of both the patient and informal caregiver. This 
care plan is periodically evaluated in a multidisciplinary meeting with the GP, elderly care 
physician, dementia CM and other involved care services.
We will measure whether the patients with dementia and their informal caregivers are 
treated by single component dementia case management, CONCERN or care as usual (no CM).
Patients and their informal caregivers
All patients in the participating general practices with a diagnosis of dementia as registered 
in the electronic medical files of the general practice, and living at home are eligible to 
participate in this study together with their informal caregiver (spouse, child or neighbour). 
We will select patients with the International Classification of Primary Care (ICPC) code for 
dementia (P70) from the electronic medical systems. This code includes Alzheimer’s disease 
and senile dementia. We will also select patients with memory disturbance (ICPC code P20) 
who are diagnosed with dementia. Patients with an estimated life expectancy of less than 
3 months will be excluded from the current study. All patients and caregivers will receive a 
complete written description of the study and be asked to sign an informed consent docu-
ment. If the patient is unable to provide informed consent, his or her legal representative 
will be asked to provide informed consent on the patient’s behalf.
Ethical approval
This research project was presented for medical ethics review at the Committee on Research 
Involving Human Subjects (CMO) of the district Arnhem - Nijmegen, the Netherlands. The 
CMO judged that the current project is not subject to the Medical Research Involving Human 
Subjects Act (Wet Medisch-wetenschappelijk Onderzoek) and can be conducted without 
review by the CMO.
assessment instruments
Data are collected by a trained research assistant during an interview with the patient and 
the caregiver at home at baseline (T0), after 9 months (T1) and at 18 months (T2). The same 
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set of questionnaires will be used in all 3 assessments (Table 1). The outcome measures have 
good psychometric properties. The primary outcome for the patient is the NPI and that for 
the informal caregiver is the Sense of Competence Questionnaire (SCQ).
Table 1. assessment instruments
instrument t0 t1 t2
Baseline variables X
Patient Mini Mental State Examination X X X
Neuropsychiatric Inventory X X X
Cohen-Mansfield Agitation Inventory X X X
Cornell Scale for Depression in Dementia X X X
Quality of life in Alzheimer’s disease X X X
Charlson Index X
Psychotropic drug use X X X
Informal Caregiver Center for Epidemiological Studies Depression Scale X X X
General Health Questionnaire X X X
EuroQol X X X
sense of Competence X X X
Patient characteristics
The following patient characteristics will be collected at baseline (T0): age, gender, marital 
state, socio-economic status/educational level and profession, use of health care services 
(psychiatric services; home care: nursing, domestic; day care services; on waiting list for 
residential care facility or nursing home). Co-morbidity will be assessed using the Charlson 
index. The Charlson Index comprises 19 categories of International Classification of Diseases, 
9th Revision, Clinical Modification (ICD-9CM) diagnose codes and is based on a set of risk 
factors for 1-year mortality risk.18 The Charlson Index contains a weighted index for each 
disease, with a score that is a significant predictor of 1-year survival. Psychotropic drug use 
(antipsychotics, anticonvulsants, antidepressants, anxiolytics, hypnotics and medication for 
dementia) will be collected in all 3 assessments.
Neuropsychiatric symptoms
The Neuropsychiatric Inventory (NPI), developed by Cummings19,20, will be the primary 
outcome. This inventory assesses 12 neuropsychiatric symptoms in dementia outpatients. 
The validity and reliability of the NPI21 and of its Dutch version22 were previously established. 
Since then, the NPI has been the most widely used rating scale for the assessment of NPS. 
The NPI comprises 12 categories of problem behaviour, as follows: delusions, hallucinations, 
agitation/aggression, depression, anxiety, euphoria, disinhibition, irritability/lability, apathy, 
aberrant motor activity, sleeping disorder and eating disorder. For each positive symptom, 
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the severity and frequency are scored on the basis of structured questions administered 
to the patients’ caregiver. The continuous score for each symptom is obtained by multiply-
ing severity (1 - 3) by frequency (1 - 4). In line with previous studies8,13-16, a score of 4 or 
more on one symptom will be taken to indicate the presence of specific ‘clinically relevant’ 
symptoms. Caregiver distress is also assessed (0 - 5), but is not calculated in the NPI total 
score. Frequency and severity scores of individual symptoms can be multiplied (FxS score) 
and summed over 12 items, yielding a total NPI score that ranges from 0 to 144. The fol-
lowing five NPI factor scores (based on the findings of previous studies) will be used23,24: 
(1) agitation, consisting of agitation/aggression, euphoria, disinhibition and irritability; (2) 
depression, consisting of depression and anxiety; (3) psychosis, consisting of hallucinations 
and delusions; (4) psychomotor agitation, consisting of aberrant motor behaviour and night-
time behaviour, and (5) apathy, consisting of apathy and eating disorder.23 The NPI will be 
assessed by a trained interviewer during an interview with the informal caregiver.
The Cohen-Mansfield Agitation Inventory (CMAI), originally developed by 
Cohen-Mansfield25, is the most widely used assessment scale for measuring the frequency 
of agitation and aggression. This inventory defines agitation as inappropriate verbal, vocal or 
motor activities not explained by apparent needs or confusion. The informant is the patient’s 
caregiver. Symptoms are assessed for the preceding 2 weeks. The original and translated 
Dutch version was found to be valid and reliable.26-28 It consists of 29 individual items and can 
be categorized in 3 subscales, which assess physically aggressive (directed against a person 
or object), physically non-aggressive (not directed against a person or object, such as pacing 
and wandering) and verbally agitated behaviour. Items are scored on a 7-point frequency 
scale, as follows: 1 = never; 2 = < once a week; 3 = 1 - 2 times per week; 4 = several times 
per week; 5 = 1 - 2 times per day; 6 = several times per day; 7 = several times per hour.26 In 
community-dwelling persons with Alzheimer’s disease, the CMAI appears useful as an over-
all measure of behavioural disturbances, but scoring by subscale does not seem applicable.29
The Cornell scale for depression in dementia (CSDD) is widely used for the screening of 
depressive symptoms in dementia. The CSDD consists of 19 items, each rated as 0 = absent, 
1 = mild or intermittent or 2 = severe. The scores of the individual items are summed, and 
a cut-off of 8 or more indicates depression.30 With a cut-off value of > or = 6 the CSDD has a 
sensitivity and specificity of 93 % and 97 %, respectively. It seems equally valid in demented 
and non-demented populations.31 The CSDD will be administered by interviewing the infor-
mal caregivers about their observations of the patients’ behaviour.
Cognition
Cognition will be assessed by the Mini-Mental State Examination (MMSE), which is the most 
widely used screening instrument to detect cognitive impairment.32 It has a fair reliability 
and construct validity, with a high sensitivity for moderately to severe cognitive impair-
ment and a lower sensitivity for mild cognitive impairment.33 It comprises items that test 
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orientation, attention, memory, language and constructive abilities. An important bias in 
using the MMSE is the extensive use of language, which leads to unreliable results in aphasic 
patients and patients who are incapable of speaking the local language.33
Quality of life
The Quality of life in Alzheimer’s disease (Qol-AD) is used to measure quality of life. It is an 
easy-to-use 13-item instrument that covers physical health, energy, mood, living situation, 
memory, family, marriage, friends, self as a whole, ability to do chores around the house, 
ability to do things for fun, money and life as a whole. Each of the 13 items is rated on a 
4-point Likert scale, as follows: 1 - ‘poor’; 2 - ‘fair’; 3 - ‘good’ and 4 - ‘excellent’.34,35 Logsdon 
found satisfactory validity and reliability, but a limited use for patients with an MMSE score 
of less than 10.36 In other studies, the Qol-AD showed very good psychometric properties, 
with satisfactory reliability and validity. Furthermore, it can be completed with people with 
a wide range of severity of dementia.37-40
Informal caregiver characteristics
The following general characteristics of the informal caregivers will be collected at baseline 
(T0): age, gender, marital state, socio-economic status/ educational level and profession.
Impact on informal caregiver
The psychological burden of caring for a patient with dementia, measured using the Sense of 
Competence Questionnaire (SCQ), will be the primary outcome for the informal caregivers. 
The SCQ is based on the family-crisis model41 and derived from Zarit’s Burden Interview.42 
This interview was developed for informal caregivers of patients diagnosed with dementia 
and consists of 27-items that are rated on a 5-point scale, as follows: 1 ‘yes, completely 
agrees’, 2 ‘yes, agrees’, 3 ‘on the one hand agrees but on the other hand disagrees’, 4 ‘no, 
disagrees’ and 5 ‘no, completely disagrees’.43,44 The SCQ consists of the following three 
subscales: 1. satisfaction with the elderly person as the recipient of care (7 items; range 7 - 
35; Cronbach’s alpha = 0.55); 2. satisfaction with one’s own performance as a caregiver (12 
items; range 12 - 60; Cronbach’s alpha = 0.63); and 3. consequences of involvement in care 
for the personal life of the caregiver (8 items; range 8 - 40; Cronbach’s alpha = 0.50). For each 
dimension, higher scores indicate a better sense of competence. Overall sum-scores range 
from 27 to 135.43,45,46 The validity and usefulness of the SCQ when applied to informal care-
givers of older adults with dementia symptoms (i.e., cognitive impairment, pre-diagnostic 
dementia or dementia in its early stages) has also been studied. The 3 subscales of the SCQ 
showed good homogeneity and feasibility, but their construct validity was insufficient. Only 
the subscale ‘consequences of involvement in care for the personal life of the caregiver’ was 
found to be partly valid.44
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Depression
The Center for Epidemiological Studies Depression Scale (CES-D) is a 20-item instrument 
that assesses the frequency of experienced depressive symptoms within the past week. The 
items are rated on a 4-point Likert scale from 0 ‘rarely or none of the time to 3 ‘most or all of 
the time’. Scores range from 0 to 60. A score of 16 or over has been clinically associated with 
a greater risk of depression.47,48 Test-retest reliability at 3-month intervals over a 12-month 
period for the CES-D was reported to be 0.49 - 0.54.47 This instrument has been widely used 
in dementia research and most of these studies have used the CES-D total score.49-54 The 
original 4-factor model of item responses is informative for identifying meaningful clusters 
of depressive symptoms in dementia caregivers.55,56
General health
The General Health Questionnaire (GHQ-12) is a 12-item questionnaire, with sum scores 
ranging from 0 to 36 (lower scores indicate better health status).57 It is a widely used self-
report instrument, that is assumed to cover a wide range of common psychiatric morbid-
ity, in particular, anxiety and depressive disorders. The GHQ was originally developed as a 
screening instrument for use in general practice. Several short-form versions (30, 28, 20 and 
12 items) of the original 60-item version have been developed. Good psychometric proper-
ties have been reported, in particular for the GHQ-12.58,59
EuroQol (EQ-5D) is a self-administered questionnaire in which respondents evaluate their 
health state “today” on the following 5 dimensions: mobility, self-care, usual activities, pain/
discomfort and anxiety/depression. A 1-to-3 scale is used for each dimension, representing 
no problem, some problem, or extreme problem for the subject to engage in the activity 
alone; for the pain and anxiety items, the three ratings relate to the severity of symptoms. 
The instrument also has a visual analog scale “thermometer” (VAS), a 20-cm scale anchored 
at 0 “worse imaginable health state” and 100 “best imaginable health state”.60 The EuroQol 
has been translated into several languages and has been validated and employed in many 
studies on general populations and subjects with mild dementia.61,62
Data analysis
All data will be analyzed using the Statistical Package for Social Science 20.0 (SPSS 20.0). 
Descriptive analysis will be used for general patient and caregiver characteristics, disease 
characteristics and time to death or time to institutionalization. Only data of patients and 
caregivers with complete follow-up of 18 months will be used for data analysis. Patient and 
caregiver characteristics of withdrawals (subjects included, but no data received) and losses 
to follow-up/drop-outs will be described and compared with the patients and caregivers 
who will complete follow-up. If patients become institutionalized during follow-up, data 
collection will be continued with the same informant/informal caregiver. Patient and care-
giver characteristics, baseline MMSE and baseline NPI total scores will be compared to the 
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non-institutionalized subjects. If these data are comparable, then they will be used for data 
analysis.
The frequency (point and cumulative prevalence), cumulative incidence, and persistence 
of symptoms are expressed as the percentage of patients with scores greater than 3 on any 
item of the NPI, at study onset and/or at any follow-up evaluations. Point prevalence will 
be defined as the proportion of patients with specific symptoms at each assessment. The 
accumulative prevalence will be defined as the proportion of patients developing a specific 
symptom on at least one assessment over the 18-month study period. The cumulative in-
cidence will be rated as the proportion of patients who are symptom-free at baseline but 
develop the specific symptom at subsequent assessments. A symptom will be considered as 
persistent if it was present on at least two subsequent assessments, regardless of time of 
first manifestation of the symptom. In addition, the proportion of patients with persistence 
of symptoms during all 3 assessments will be calculated.
Univariate analysis will be performed to identify determinants of NPS in patients with 
dementia in primary care as dependent variable for each assessment. Univariate analysis 
will also be performed to identify determinants of caregiver distress as dependent variable. 
Independent determinants will be multicomponent collaborative care (CONCERN), single 
component dementia case management, NPS at baseline, cognition and use of health care 
services (home care: nursing and domestic; use of day care services).
All determinants will then be tested in a multivariate regression analysis to determine 
their unique contribution to the course of NPS and informal caregiver distress. To take into 
account the clustering of patients with dementia/informal caregivers in general practices 
and the repeated measurements within patients’ random coefficient analyses will be used.
According to the National Public Health Compass, developed and coordinated at the Dutch 
National Institute of Public Health and the Environment, absolute prevalence of patients 
with dementia in registrations of general practices is 20 per general practice per year. Based 
on their interest in participating 18 practices were selected. With an assumed response rate 
of 50 % and loss to follow-up rate of 30 % after 18 months, the expected study population 
will be 126 patients with dementia. In analysis of causal influences in observational data, 
as a rule of thumb 1 candidate predictor can be studied for every 10 patients. For logistic 
regression, this rule can be relaxed to 5 - 9 events per candidate predictor.63 The assumed 
prevalence rate of NPS in primary care is 60 %.16,17 The number of independent variables 
in this study will be 7. Therefore 126 patients with dementia will suffice for the regression 
analyses.
Proportions (prevalence, incidence, persistence) can be estimated with absolute precision 
of 10 % and a confidence level of 95 % taking into account design effect of 1.25 based on 
an intraclass correlation coefficient (ICC) of 0.05 and a mean cluster size of 6, assuming a 
conservative estimate of anticipated proportion of 50 %.
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Discussion
To our knowledge, this study is the first to focus on the course of NPS in patients with 
dementia and informal caregiver distress in primary care. All selected outcome measures 
have been proven and validated. The data will be collected by one research assistant. There-
fore, measurement inaccuracies will be minimal.
This study has some limitations. Only 19 % of the GPs we invited are willing to participate. 
This might limit the generalizability of the findings. Data will be collected at baseline, after 
9 months and after 18 months. Variations in course between two successive assessments 
will be unknown. Because this is a naturalistic study, the course of NPS can be influenced 
by psychosocial and pharmaceutical interventions that we will not specifically assess in this 
study. Furthermore, we will select patients coded with dementia as classified in the ICPC 
code P70 and P20. Dementia in these patients is not necessarily defined with international 
criteria and Dutch consensus guidelines, causing a risk of bias. In the different general prac-
tices variability exists in the usage of the classification according to ICPC in the electronic 
medical files. However, because GPs often wait before diagnosing dementia, we expect that 
this bias will be small. On the other hand, this may bias the sample towards a more severe 
spectrum of illness.
The current study will provide more detailed information about consequences of NPS for 
the quality of life of both patients and informal caregivers as well as the influence of NPS 
on depressive symptoms and experienced health state of the caregiver, which is clinically 
important. The data will help GPs and other professionals in planning follow-up visits and 
in the timing of offering psycho-education, psychosocial interventions and the provision of 
care. It will enlarge their awareness of NPS in their patients with dementia. An individually 
tailored approach for patients with dementia and their informal caregivers may offer more 
and better treatment opportunities.
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abstract
background
Neuropsychiatric symptoms (NPS) often occur in patients with dementia. Understanding the 
course of NPS in dementia is important for health care professionals for psycho-educational 
purposes and adequate and timely interventions to prevent or diminish NPS as much as 
possible.
methods
We conducted a systematic literature search in several electronic databases. We combined 
search strings for the terms dementia, community-dwelling, cohort studies and NPS. Screen-
ing titles and abstracts, assessing the methodological quality and data-extraction were 
independently conducted by at least two authors.
Results
This literature search revealed 6605 unique records of which 23 studies were included in data 
synthesis. In total 7184 patients participated in the included studies with a mean number 
of 312. Sixty percent of the subjects were female and the mean age of all subjects was 74.8 
years. Follow-up varied between 1 and 6 years; in 17 studies loss to follow-up was less than 
20 % per year. NPS are highly prevalent, incident and persistent although frequency param-
eters vary considerably across studies. Delusions/delusional misidentification, wandering/
agitation, aberrant motor behaviour/motor hyperactivity and apathy are the most common 
NPS. For hallucinations, delusions/delusional misidentification, paranoia, aggression, wan-
dering/agitation, aberrant motor behaviour/motor hyperactivity, disinhibition, apathy and 
sleep disturbance increasing trends in point prevalence rates have been found.
Conclusions
NPS in community-dwelling patients are frequent and persistent. The increasing trends 
of several NPS in the course of dementia require a preventive approach of professional 
caretakers. For such an approach, a timely diagnosis and adequate professional support to 
prevent or diminish these problems is necessary.
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introDuction
Dementia is a chronic and progressive disorder with great impact on people with dementia 
and their family members.1 Neuropsychiatric symptoms (NPS), also termed behavioural and 
psychological symptoms of dementia (BPSD), frequently complicate the course of dementia. 
Examples of NPS are psychosis (delusions and hallucinations), depressive mood, anxiety, 
irritability/lability, apathy, euphoria, disinhibition, agitation/aggression, aberrant motor 
activity, sleep disturbance and eating disorder. Studies from various countries reported NPS 
prevalence rates in community-dwelling people that ranged from 61 to 96 %.2-5 NPS result in 
lower quality of life for both the people with dementia and their caregivers and affect the 
quality of the relationship with the caregivers.6,7
Nursing home admission is predicted by NPS, severity of cognitive impairment, Alzheimer’s 
dementia, high rates of functional dependence and depressive symptoms.8 Major depression 
is a predictor of early institutionalization in the first year following the dementia diagnosis.9 
The future severity of NPS is predicted by the baseline severity of NPS, stage of dementia 
and use of support services.10
For people with dementia and their informal caregivers, as well as general practitioners 
and the other professionals involved in long-term care, it is important to understand the 
course of NPS. If we are able to recognize patients at risk of persistent NPS we can develop 
individual approaches in the different stages of dementia for both patients with dementia 
and their professional and informal caregivers. Knowledge on NPS in dementia is important 
for psycho-educational purposes and timely interventions to prevent or diminish NPS as 
much as possible. The aim of this systematic review is to study the prevalence and course of 
NPS in community-dwelling patients with dementia.
methoDs
We performed a systematic review of prospective cohort studies according to the guidelines 
of the Cochrane Collaboration and the PRISMA-Statement (Preferred Reporting Items for 
Systematic Reviews and Meta-Analysis).11,12 Conform the PROGnosis RESearch Strategy 
(PROGRESS) we aimed for studies that can be classified as fundamental prognosis research.13 
The following steps were described in a predefined research protocol: (1) inclusion criteria; 
(2) exclusion criteria; (3) search methods for identification of studies; (4) data extraction; (5) 
assessment of methodological quality; (6) data synthesis.
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Inclusion criteria
Typesofstudies. This review included prospective cohort studies.
Typesofparticipants. Patients with dementia.
Setting. Primary care or community dwelling patients.
Studysize. At least 25 or more patients at baseline.
Follow-up. Three months or more.
Typesofoutcomemeasures. Neuropsychiatric symptoms.
Exclusion criteria
Typesofstudies.  Case-studies, case-control studies, clinical trials, cross-sectional 
studies and trend studies (repeated cross-sectional studies).
Typesofparticipants. Caregivers, patients with mild cognitive impairment (MCI).
Setting.  Assisted living facilities, chronic care institutions, home of 
the aged, housing for the elderly, intermediate care facilities, 
nursing home and residential care.
Search method for identification of studies
On November 27th, 2012, we conducted an electronic search in the databases PubMed, 
EMBASE, CINAHL, PsycINFO and the Cochrane Library for all studies that were published 
until that date. We modified a previously used search strategy for residents with dementia 
in long-term care institutions for this review on patients with dementia in primary care.14,15 
We combined search strings for dementia, primary care, cohort studies and NPS with the 
Boolean operator AND. An overview of the terms used in the computerized search strategy 
as performed in PubMed is presented in supplementary table 1. The search strategy was 
adapted for the other four databases to fit database-specific features. The reference lists of 
selected articles and previous reviews on the course of NPS in primary care were searched 
for articles not identified by the initial search. The results of the 5 databases were aggregated 
and duplicates were deleted. No books or dissertations were included in this review. There 
were no limitations regarding the language of the publication.
Selection method
Two authors (PB and RBW) independently screened titles and abstracts to identify eligible 
papers. When there was insufficient information to evaluate the inclusion and exclusion 
criteria, we retrieved the full text article. We excluded all studies that clearly did not meet 
all inclusion criteria or that met at least one of the exclusion criteria. Inter-rater agreement 
about in and exclusion based on titles and abstracts was measured and reported as Cohen’s 
kappa (κ).16 Subsequently, two authors (PB and RBW) independently reviewed the full 
publications of the remaining papers. We discussed disagreements in consensus meetings. 
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All discussions led to consensus about inclusion. When needed we corresponded with co-
authors of this paper for further information to clarify study eligibility.
Data extraction and assessment of methodological quality
At least 2 reviewers (PB, RBW and/or PLL) independently extracted the information from 
the selected publications by using standardized and pre-tested data-extraction forms. The 
extracted information involved data on study population, diagnostic criteria, inclusion and 
exclusion criteria, setting, type of prognostic factors, duration of follow-up, outcomes, and 
data on methodological quality. In a case of disagreement, we reached consensus after 
discussion with all 3 reviewers.
For assessing the methodological quality of the included studies we used a standardized 
checklist of predefined criteria (see Table 1), which has been used in previous prognostic 
reviews 17 and is based on theoretical considerations and methodological aspects described 
earlier.18-20 Two authors (PB and RBW) tested the quality assessment checklist in a pilot as-
sessment. Each criterion was scored positive (+, design or conduct adequate), negative (-, 
design or conduct inadequate), or unclear (?, insufficient information). The total quality score 
is expressed as the sum of all criteria that are scored positive. The maximum quality score is 
21 and we calculated the quality of a study as the percentage of the maximum score. We dis-
cussed disagreements in the scoring of quality items in consensus meetings and categorized 
the quality criteria into four major forms of bias: selection bias, completeness of follow-up, 
information bias, and confounding. For judging selection bias, quality criteria description 
of inception cohort, study population, relevant inclusion and exclusion criteria, definition 
of dementia and NPS, response rate ≥ 75 % and information about non-responders versus 
responders were used. The quality criteria loss to follow-up ˂ 20 % per year and information 
about completers versus those lost to follow-up/dropouts were used to judge completeness 
of follow-up. Furthermore, the quality criteria standardized assessment of symptoms and 
functional outcome, as well as potential prognostic factors were used to judge information 
bias; the quality criteria description of possible treatment in cohort and appropriate univari-
ate crude estimates and multivariate analysis techniques were used to judge confounding. 
Finally, the quality criteria number of subjects in study population ≥ 100 at baseline, follow-
up of at least 12 months, prospective data collection, clinically relevant outcome measures, 
frequencies of most important outcome measures and prognostic factors presented and 
influence of prognostic factors presented were used to judge descriptive items. We defined 
studies with a quality score of 60 % or higher as studies with high quality.17,21
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Table 1. Explanation of the criteria for assessing the methodological quality.
A. Descriptionofinceptioncohort.
Positive if it is described in what setting the participants were recruited (i.e. general population, 
patients attending the general practitioner, inpatient or outpatient setting).
B. Descriptionofstudypopulation.
Positive if it is described which participants from the inception cohort are recruited and if age and 
sex are described.
C. Descriptionofrelevantinclusionandexclusioncriteria.
Positive if it is described how participants were identified with dementia.
+ = Dementia diagnosed by standardized diagnostic interview and or assessment scales
− =  Dementia not diagnosed by standardized diagnostic interview (including DSM) or assessment 
scale
? = Not clear
D. Definitionofdementiaandneuropsychiatricsymptoms.
Positive if the definition of dementia and neuropsychiatric symptoms is described.
E. Numberofsubjectsinstudypopulation≥100.
Positive if the number of subjects with dementia in the study population was at least 100 at 
baseline.
F. Response rate≥75 %.
Positive if response rate is at least 75 %. Response rate: the number of patients in the study 
population at baseline, divided by the number of subjects in the inception cohort.
G. Informationaboutnon-respondersversusresponders.
Positive if demographic or clinical information (such as age and sex) was presented for responders 
and non-responders, or if there was no selective response, or no nonresponse.
H. Follow-up of at least 12 months.
Positive if the follow-up period was at least 12 months.
I. Loss to follow-up < 20 %peryear.
Positive if mean number of patients with dementia is less than 20 % per year. Loss to follow-up: the 
number of patients in the study population at baseline minus the number of patients at the main 
NPS outcome measure for each year, divided by the number of patients in the study population at 
baseline.
J. Informationaboutcompletersvs.thoselosttofollow-up/dropouts.
Positive if demographic or clinical information (such as age and gender, disease characteristics, and 
other potential prognostic predictors) was presented for completers with dementia and those lost 
to follow-up at the main moment of outcome measurement, or if there was no selective loss to 
follow-up, or no loss to follow-up.
K. Prospectivedatacollection.
Positive if main outcome measures on potential prognostic predictors were collected 
prospectively.
L. Descriptionofpossibletreatmentincohort.
Positive if treatment subsequent to inclusion in cohort is fully described or standardized. Also 
positive if no treatment is given.
+ = treatment/multivariate correction for treatment in analysis, or no treatment given
− = different treatment regimens, not clear how outcome is influenced by it
? = not clear if any treatment is given
M. Clinicallyrelevantoutcomemeasures.
Positive if at least one clinically relevant outcome measures is presented.
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Data synthesis
The following main study characteristics were extracted from the papers: setting/country, 
number enrolled in cohort, criteria for diagnosis (dementia and NPS), duration of follow-up 
(years and range), loss to follow-up (number and %), gender and age (years ± S.D. and range) 
at baseline, living situation of participants at baseline, number of assessments and presenta-
tion of results for number of patients per assessment (PPA) or completers.
Information on the course of NPS is presented in three subgroups according to the factor 
analysis of Aalten.22 The three subgroups we present are a psychotic subgroup including 
hallucinations, delusions, delusional misidentification and paranoia, a hyperactivity sub-
group including agitation, aggression, euphoria, disinhibition, irritability and aberrant motor 
behaviour and finally an affective subgroup including depression, anxiety, apathy, night-time 
behaviour disturbances and eating abnormalities. Data are presented as point and cumula-
tive prevalence, (cumulative) incidence, persistence and resolution per assessment. Point 
prevalence is defined as the proportion of patients with specific NPS at each assessment. The 
Table 1. Explanation of the criteria for assessing the methodological quality. (continued)
N. Standardizedassessmentofsymptomoutcome.
Positive if standardized questionnaires or objective outcome measurements of NPS were used for 
each follow-up measurement.
O. Standardizedassessmentoffunctionaloutcome.
Positive if standardized questionnaires or objective outcome measurements were used for each 
follow-up measurement.
P. Standardizedassessmentofpotentialprognosticfactors.
Positive if standardized questionnaires or objective measurements of potential prognostic factors 
were used at baseline.
Q. Appropriateunivariatecrudeestimates.
Positive if separate univariate (repeated measures) analysis of variance was calculated for each 
dependent measure.
R. Appropriatemultivariateanalysistechniques.
Positive if multivariate (repeated measures) analysis of variance was calculated for changes among 
the dependent measures occurring during the follow-up interval.
S. Frequenciesofmostimportantoutcomemeasurespresented.
Positive if frequency, percentage or mean, median (interquartile range), and standard deviation/
confidence intervals are reported of the most important outcome measures
T. Frequenciesofmostimportantprognosticfactorspresented.
Positive if:
a. frequency of percentage is reported, or
b. mean and standard deviation or standard error are reported, or
c. median and interquartile range are reported, or
d. if the influence of each separate factor is reported
U. Influenceofprognosticfactorspresented.
Positive if the influence of each separate prognostic factor on the natural course of NPS is 
presented.
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cumulative prevalence is defined as the proportion of patients developing a specific NPS on 
at least one assessment over the follow-up period including baseline assessment. Incidence 
is defined as the proportion of patients who develop a specific NPS at one assessment but 
did not show the symptom on the preceding assessment. The cumulative incidence is de-
fined as the proportion of patients who are symptom free at baseline, but develop a specific 
NPS at next assessments. A symptom is persistent if it is present on at least two subsequent 
assessments, regardless of time of first manifestation of the symptom. Resolution is defined 
as the proportion of patients who showed a specific NPS at one assessment but not at the 
next assessment and is displayed for each successive assessment.22 Not statistically tested 
increasing or decreasing changes are presented as trends. In case of significant changes p-
values are presented.
results
Search results and study selection
The process of selecting publications for the review is illustrated in Figure 1. We retrieved a 
total of 9167 publications from searches of the various electronic databases (PubMed 2370, 
EMBASE 2428, CINAHL 2899, PsychINFO 1123 and the Cochrane Library 347) and 15 through 
hand-search of reference lists of other studies. After screening the titles and abstracts, 53 
publications seemed eligible according to the inclusion and exclusion criteria. The inter-
observer agreement (unweighted κ) for inclusion between the two reviewers (PB, RBW) 
for screening titles and abstracts was κ = 0.60 (95 % CI: 0.43 - 0.76), which is considered 
‘moderate’ agreement.16 Proportion of agreement was 0.9965 (95 % CI: 0.9947 - 0.9977). 
After assessing the full publications, 23 papers were definitively included in our review.23-45 
Major reasons for excluding publications were retrospective data analysis, studies on 
samples of informal caregivers and major or unclear part of participants living in institutions.
Study characteristics
The quality score of the 23 studies ranged from 52 % to 86 % (see Table 2). Twenty of these 
have a score of 60 % or higher. Selection bias was present in all studies. Response rate was 
given in only two studies and information about responders versus non-responders was 
given in only one other study. Confounding was present in 19 studies and in 17 studies infor-
mation bias was present. Follow-up in all studies was at least 12 months. In 17 studies loss 
to follow-up was less than 20 % per year. After close inspection, no direct association was 
found between setting/country, number enrolled in cohort, criteria for diagnosis, duration 
of follow-up, loss to follow-up, gender, age, living situation, year of publication and the total 
quality score.
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Eight studies are performed in the United States of America (USA), five in the United 
Kingdom, two in Germany and two in France, one study in Japan, one study in Finland 
and one study in the Netherlands (see Table 3). Two studies are performed in 3 sites (USA, 
France, Greece) and 1 study is performed in 12 European countries. In total 7184 patients 
participated in the included studies. The mean number of study participants was 312 and 
the median number 170 (range 30 - 2288).
Dementia was diagnosed according to several diagnostic criteria and in one of them 
according to histopathological criteria.34 NPS were assessed by using 15 different instru-
ments. Five studies used the Columbia Scale for Psychopathology in Alzheimer’s disease 
(CUSPAD) of which three papers described the results of the Predictors study, four used 
the Neuropsychiatric Inventory (NPI) of which two papers described the results of the 
Reseau sur la Maladie d’Alzheimer Francais (REAL.FR) study, three studies used the Pres-
ent Behavioural Examinations (PBE) of which two papers described the results of the same 
study and two studies used the Diagnostic and Statistical Manual of Mental Disorders 
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Figure 1. Results of database searches and selection of studies. 
 
 
 
 
9 67 records identified through 
database searching 
• PubMed: 2370 
• EMBASE: 2428 
• CINAHL: 2899 
• PsychINFO: 1123 
• Cochrane Library: 347 
15 records identified through 
hand-search of reference lists of 
other studies 
9182 records identified 
30 full-text articles excluded after 
discussion for consensus 
23 studies included in data 
synthesis 
53 of full-text articles assessed for 
eligibility 
6552 articles excluded 
6605 titles and abstracts screened 
2577 records after duplicates removed 
figure 1. Results of database searches and selection of studies.
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The course of neuropsychiatric symptoms in community-dwelling patients with dementia: a systematic review 
(DSM) criteria for delusions and hallucinations. The Cohen Mansfield Agitation Inventory 
(CMAI), Cornell Scale for Depression in Dementia (CSDD), DSM criteria for depression, DSM 
criteria for psychosis, Burns’ Symptom checklist, Caretaker Obstreperous - Behavior Rating 
Assessment (COBRA) scale, Behavioural Abnormalities in Alzheimer’s Disease (BEHAVE-AD), 
Troublesome Behavior Scale (TBS) and Hamilton Depression Rating Scale (HADRS) were each 
used in one study. One study used a semi-standardized carers’ interview and one study used 
a structured clinical interview.
Follow-up varied between 1 and 6 years with a mean of 3 years and median of 3.5 years. 
Twenty-two studies reported data on loss to follow-up: a total of 3024 patients (44 %) were 
lost to follow-up with a mean of 38 % (range 0 - 85,3 %)
Nineteen studies reported data on gender. In these 19 studies 2256 of the participants 
were male (40 %) with a mean of 119 per study and median 75 (range 13 - 857) and 3376 of 
the participants were female (60 %) with a mean of 178 per study and median 102 (range 
10 - 1431). In the 20 studies reporting data on age the mean age was 74.8 years (range 68.8 
- 79.9). Two of these studies reported data on age per diagnosis. In one study for dementia 
with Lewy bodies (LBD) 76.5 ± 7.9 years and for Alzheimer’s disease (AD) 81.1 ± 6.6 years. 
In the other study for AD 76.5 ± 7.1 years and for vascular dementia (VaD) 71.4 ± 8.1 years.
Three studies reported an outpatient setting, but did not give specific information on the 
living situation of the subjects at baseline.23,32,43 Two studies reported that a small part of 
the subjects were not living at home. One study reported that 91.1 % of the subjects lived 
at home, 6.8 % in nursing home, 1.3 % in retirement home, 0.9 % other living situations.24 
The other study reported that 5.9 % of the subjects were recruited from a long-term care 
facility.26
After close inspection, no direct association was found between total quality score and the 
frequency parameters of the studies.
Course of NPS in patient with dementia in primary care
In 22 studies 2 - 12 assessments were conducted (see Table 4). In one study the number 
of assessments was not given.25 Twelve studies presented data of PPA, ten studies pre-
sented data of completers and for one study this was not clear. In one study the results were 
presented in figures per stage of dementia using the Clinical Dementia Rating scale (CDR) 
and not in numbers.35 This study concluded that the patterns of NPS change depended on 
the baseline severity of AD. The NPS frequencies peaked in the middle stage (CDR 2) and 
followed a downward trend thereafter. Two studies reported on the psychotic, hyperactiv-
ity and affective subgroup as a whole, as well as on individual symptoms.39,44 The study of 
aalten et al. reported point and cumulative prevalence rates, (cumulative) incidence and 
persistence rates on all individual NPI symptoms as well as on the subgroups (see Table 4).
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Any symptom
Ten studies reported on NPI total scores or on NPS in general without symptom specification 
of which seven studies reported on PPA and three studies on completers.24,30,31,33,38-41,44,45 
The point prevalence rates ranged between 11 % and 90 % (PPA 11 % - 88 % and completers 
42 % - 90 %) and cumulative prevalence rates ranged between 49 % and 95 % (PPA 49 % - 
95 % and completers 66 % - 88 %). Incidence rate was 47 % (PPA), cumulative incidence rates 
ranged between 27 % to 74 % (PPA), persistence rates ranged between 8 % to 65 % (PPA) 
and resolution rate was 53 % (PPA). Two studies presented NPI scores per assessment and 
not frequency parameters and these increased during follow-up (one PPA and one com-
pleters).40,45 One of these 2 studies (on completers) reported that NPI scores were stable in 
10 %, worsened in 51 % and improved in 38 % of the subjects.45
Psychotic subgroup
In the two studies (one on PPA and one on completers) that reported on the psychotic sub-
group as a whole the point prevalence rates ranged between 13 % and 34 % (PPA 23 % - 34 % 
and completers 13 % - 21 %). Cumulative prevalence rate and cumulative incidence rate were 
53 % and 37 %, respectively (PPA) and persistence rates ranged between 3 % and 12 % (PPA). 
Point prevalence rates on psychotic symptoms (not specified) presented in one study ranged 
between 31 % and 49 % (PPA).41
Hallucination point prevalence rates ranged between 0 % (severe symptoms) to 43 % (PPA) 
and cumulative prevalence rates ranged between 32 % and 70 % (PPA 34 % - 70 % and com-
pleters 32 % - 47 %). In one study there was a trend of an increasing rate of hallucinations 
during follow-up (completers).39 One study reported an incidence rate of 20 % (completers)30 
and another study (completers) reported incidence rates separately for visual hallucina-
tions 16 % (LBD 30 % and AD 13 %) and for auditory hallucinations 13 % (LBD 28 % and AD 
7 %). Persistence rate ranged between 0 % and 64 % (completers). One study (completers) 
reported persistence rates separately for visual hallucinations 64 % (LBD 77 % and AD 26 %) 
and for auditory hallucinations 42 % (LBD 41 % and AD 45 %).27 Resolution rates ranged 
between 27 % and 61 % (completers).
Delusion/delusional misidentification point prevalence rates ranged between 5 % (severe 
symptoms) and 61 % (PPA). In two studies (PPA) there was a trend that delusions/delusional 
misidentification increased during follow-up25,31, but in 1 study (PPA) there was a trend that 
these symptoms decreased.29 Cumulative prevalence rates ranged between 34 % to 80 % 
(one study completers 53 %). One study (completers) reported an incidence rate of 30 % 
for delusions and 17 % for delusional misidentification30 and another study (completers) 
reported incidence rates for delusions 25 % (LBD 30 % and AD 24 %) and for delusional 
misidentification 16 % (LBD 30 % and AD 12 %).27 Cumulative incidence rate was 34 % (PPA). 
Persistence rate was 0 % for delusions in one study32 and in another study 42 % (LBD 40 % 
and AD 44 %) for delusions and 25 % (LBD 30 % and AD 18 %) for delusional misidentifica-
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tion.27 One study reported a resolution rate of 57 %32 and another study 73 % for delusions 
and 65 % for delusional misidentification (all completers).30
For hallucinations and/or delusions together (PPA) cumulative prevalence rate was 47 %, 
persistence rate was 87 % and resolution rate was 13 %.28,34 Increasing cumulative incidence 
rates ranged between 20 % and 51 % (PPA).28
On paranoia (PPA) increasing point prevalence rates were reported and ranged between 
20 % and 46 %.31 For severe symptoms there was no trend and point prevalence rates ranged 
between 3 % to 13 %.31
Hyperactivity subgroup
In the two studies that reported on the hyperactivity subgroup as a whole the point preva-
lence rates ranged between 34 % and 65 % (PPA 46 % - 65 %, completers 34 % - 54 %) and in 
both studies, there was a trend that hyperactivity increased during follow-up.
(Physical) aggression point prevalence rates ranged between 6 % and 26 % (all three 
studies PPA).25,26,31 In two studies there was a trend that (physical) aggression increased dur-
ing follow-up.25,26 Cumulative prevalence rates ranged between 40 % and 74 % (PPA 40 % and 
41 % and completers 74 %) and incidence rate was 36 % (completers), persistence rate was 
22 % (completers) and resolution rate was 25 % (completers).
Wandering or agitation point prevalence rates ranged between 18 % and 62 %. In all three 
studies (PPA) there was a trend that wandering or agitation increased during follow-up.25,26,39 
Cumulative prevalence rates ranged between 40 and 100 %, persistence rate was 0 % - 67 % 
and resolution rate 2 %.
On mechanical and motor abnormalities/motor hyperactivity two studies reported in-
creasing point prevalence rates that ranged between 10 % and 61 % (PPA 10 % - 61 % and 
completers 14 % - 29 %).31,39 For severe symptoms (PPA) there was no trend and these point 
prevalence rates ranged between 0 % and 16 %. Cumulative prevalence rate was 50 % (PPA) 
and incidence rate was 20 % (completers). One study (completers) reported an increase in 
aberrant motor activity during follow-up.45
Affective subgroup
In the two studies that reported on the affective subgroup as a whole the point prevalence 
rates ranged between 23 % and 80 % (PPA 67 % - 80 % and completers 23 % - 26 %). Cumula-
tive prevalence rate was 86 %, incidence rate was 57 % and persistence rates ranged between 
5 % to 37 % (all for PPA).
Depression point prevalence ranged between 10 % and 42 % (PPA 10 % - 42 % and com-
pleters 29 % - 43 %) and two studies (one PPA and one completers) reported a decrease in 
prevalence of depression during follow-up.23,45 Cumulative prevalence rates ranged between 
20 % and 78 % (PPA 20 % and completers 22 % - 78 %) and incidence was 8 % (12 % LBD and 
6 % AD) (completers). Persistence rates ranged between 33 % and 35 % (38 % LBD and 31 % 
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AD) (completers) and resolution rate was reported in one study (completers) and was 15 %.32 
One study (PPA or completers not given) reported cumulative incidence, persistence, resolu-
tion and fluctuating rates separately for AD and VaD.43 For AD these rates were 15 %, 27 %, 
67 % and 7 %, respectively. For VaD these rates were 27 %, 67 %, 22 % and 11 %, respectively.
Anxiety point prevalence rate ranged between 18 % and 24 % (PPA) and one study (com-
pleters) reported a decreasing number of affected patients with anxiety during follow-up.45 
Cumulative prevalence rates ranged between 43 % (PPA) to 66 % (completers) and cumula-
tive incidence rate was 28 % (PPA). One study (completers) reported a persistence rate of 
12 %32 and another study presented a decreasing trend in persistence rates that ranged from 
22 % to 1 % (PPA).44 Resolution rate was reported in only one study (completers) and was 
38 %.32
Apathy point prevalence rates with increasing trend were reported in one study (PPA) 
and ranged from 43 % to 63 %.39 In another study (completers) also an increasing number of 
affected patients with apathy during follow-up was reported.45
Hyperphagia, eating change in hyperphagia and eating change in hypophagia cumulative 
prevalence rates were reported in one study (PPA).36 These rates were 26 % for hyperphagia, 
23 % for eating change in hyperphagia and 66 % for eating change in hypophagia.
One study (PPA) reported point prevalence rates on sleeping disturbance 9 % - 18 %, 
cumulative prevalence 34 %, cumulative incidence 31 % and persistence 1 % - 20 %.44 one 
study (completers) reported on sleep disturbances and an increasing number of affected 
patients with sleep disturbances during follow-up was reported.45
Discussion
We found 23 prospective cohort studies with 7184 community-dwelling patients with 
dementia. NPS in general are highly prevalent, incident and persistent although frequency 
parameters vary considerably across studies. Results presented for PPA compared to com-
pleters are diverse but not conclusive. Virtually all patients with dementia show any NPS 
during a period of 1 - 6 years. The overall quality of the studies was rather good (20 of 23 
studies have a score of 60 % or higher) although selection bias was present in all studies and 
confounding and information bias in the majority (19 of 23) of the studies.
Delusions/delusional misidentification, wandering/agitation, aberrant motor behaviour/
motor hyperactivity, and apathy are the most common NPS. For hallucinations, delusions/
delusional misidentification, paranoia, aggression, wandering/agitation, aberrant motor 
behaviour/motor hyperactivity, disinhibition, apathy and sleep disturbance increasing 
trends in point prevalence rates have been found. Decreasing trends in depression and 
anxiety have been found in some studies. For VaD compared to AD there were higher cu-
mulative incidence and persistence rates. Resolution rate is higher for AD compared to VaD. 
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NPS in the hyperactivity subgroup have higher point prevalence rates than in the psychotic 
subgroup and NPS in the affective subgroup have higher point prevalence rates than in the 
hyperactivity subgroup.
The variance in frequency parameters may partly be explained by the different assess-
ment instruments used, the different intervals between assessments and different follow-up 
periods. The increasing trends for hallucinations, delusions/delusional misidentification, ag-
gression, wandering/agitation, aberrant motor behaviour/motor hyperactivity, and apathy 
are in line with findings of studies on the course of NPS in nursing home patients with 
dementia, especially for wandering/agitation and apathy.15,46 Apparently a universal course 
of NPS exists regardless of the setting of patients with dementia. Although the development 
and course of NPS is a result of complex interactions between psychological, environmental 
and biological factors.47-49 Sleep disturbance, agitation/aggression and depression/dysphoria 
are the symptoms that causes caregivers the most emotional distress.5. Apathy is the symp-
tom that gives a negative impact on the quality of the relationship between patient with 
dementia and caregiver and is a predictor for relationship change.6
Strengths and limitations
In this systematic review, we used an extensive search strategy to identify relevant studies. 
We pre-tested the search strategy in a pilot assessment and we searched all relevant data-
bases without language restriction. Finally, we independently extracted data and assessed 
the quality of included studies with a validated checklist of predefined criteria, which has 
been used in previous prognostic reviews.17,21 We presented our results together with a 
quality score of each study to visualize the susceptibility of each study for bias, because the 
quality of the individual study influences outcomes.
There are also limitations to this review that should be acknowledged. Pooling of data 
was impossible due to the heterogeneity of the characteristics of the community-dwelling 
patients studied and the methods used. The presence of selection bias in all studies limits 
the generalizability of the results for the individual patients, but general trends in NPS have 
been found for the overall population. In two studies a small part (5.9 % and 8.9 %) of the 
sample was institutionalized. This could also influence the generalizability of the results. 
Furthermore, we included 22 studies from the USA and Europe and 1 study from Japan. 
Unfortunately, we have not been able to include any studies from Africa or South America. 
It is quite likely that the pattern of NPS and caregivers’ response may differ among various 
ethnic and cultural groups, especially between developing and developed countries. This 
also limits the generalizability of the results. The median number of participants enrolled 
in the cohorts of the included studies in this review is 170 with a wide range of 30 - 2288 
study participants. Five studies enrolled less than 100 patients into the cohort.31-34,42 These 
low numbers of participants in the cohorts limit the strength of the evidence concerning 
outcomes.
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In the included 23 studies, several diagnostic criteria were used and even more different 
assessment instruments. There was a wide range in duration of follow-up and in six studies 
loss to follow-up was more than 20 % per year. Therefore, the interpretation and comparabil-
ity of these studies has been difficult. Further studies on the course of NPS which are large 
enough to follow up a substantial amount of patients over longer periods of time and which 
will use established assessment instruments will improve comparability and will give more 
information on the persistence and resolution of NPS. Together with important prognostic 
factors such as type and stage of dementia this will give important recommendations for 
professional long-term care for community-dwelling patients with dementia.
conclusions
Delusions/delusional misidentification, wandering/agitation, aberrant motor behaviour/
motor hyperactivity and apathy are the most common NPS. For hallucinations, delusions/
delusional misidentification, paranoia, aggression, wandering/agitation, aberrant motor 
behaviour/motor hyperactivity, disinhibition, apathy, and sleep disturbance increasing 
trends in point prevalence rates have been found. The increasing trends of several NPS in 
the course of dementia require a preventive approach of professional caretakers. For such 
an approach, a timely diagnosis and adequate professional support to prevent or diminish 
these problems is necessary.
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Supplementary Table 1. Overview of computerized search strategy: terms used in PubMed.
(“Dementia”[MeSH] OR Alzheim*[All Fields] OR “CADASIL”[All Fields] OR “Dementia”[All Fields] OR “Lewy 
Body”[All Fields] OR Pick*[All Fields] OR “Prion Diseases”[All Fields])
AND
(“Community Health Services”[MeSH] OR “General Practice”[MeSH] OR “General Practitioners”[MeSH] OR 
“Independent Living”[MeSH] OR “Primary Health Care”[MeSH] OR “Community Based Care”[All Fields] OR 
“Community-Based Care”[All Fields] OR “Community Dwelling”[All Fields] OR “Community-Dwelling”[All Fields] 
OR “Community Health Services”[All Fields] OR (“Community”[All Fields] AND “Healthcare”[All Fields]) OR “Fam-
ily Doctor”[All Fields] OR “Family Doctors”[All Fields] OR “Family Physician”[All Fields] OR “Family Physicians”[All 
Fields] OR “Family Practice”[All Fields] OR “Family Practitioner”[All Fields] OR “Family Practitioners”[All Fields] 
OR “General Practice”[All Fields] OR “General Practitioner”[All Fields] OR “General Practitioners”[All Fields] 
OR “Home Care Services”[All Fields] OR “Independent Living”[All Fields] OR “General Medicine”[All Fields] OR 
“Primary Care”[All Fields] OR “Primary Health Care”[All Fields] OR “Public Health”[All Fields])
AND
(“Cohort Studies”[MeSH] OR “Cohort”[All Fields] OR “Concurrent”[All Fields] OR “Follow up”[All Fields] OR 
“Follow-up”[All Fields] OR “Longitudinal”[All Fields] OR “Prospective”[All Fields])
AND
(“Activities of Daily Living”[MeSH] OR “Affect”[MeSH] OR “Aggression”[MeSH] OR “Anxiety”[MeSH] 
OR “Appetite”[MeSH] OR “Behavioral Symptoms”[MeSH] OR “Chronic Disease”[MeSH] OR “Cogni-
tion Disorders”[MeSH] OR “Communication”[MeSH] OR “Communication Disorders”[MeSH] OR 
“Comorbidity”[MeSH] OR “Cooperative Behavior”[MeSH] OR “Delusions”[MeSH] OR “Depression”[MeSH] OR 
“Depressive Disorder”[MeSH] OR “Eating Disorders”[MeSH] OR “Environment”[MeSH] OR “Euphoria”[MeSH] 
OR “Geriatric Assessment”[MeSH] OR “Geriatric Psychiatry”[MeSH] OR “Hallucinations”[MeSH] OR “Hearing 
Loss”[MeSH] OR “Irritable Mood”[MeSH] OR “Language Disorders”[MeSH] OR “Marital Status”[MeSH] OR 
“Mental Disorders”[MeSH] OR “Mood disorders”[MeSH] OR “Natural History”[MeSH] OR “Neurobehavioral 
Manifestations”[MeSH] OR “Neuropsychological Tests”[MeSH] OR “Neuropsychology”[MeSH] OR “Pain”[MeSH] 
OR “Personality”[MeSH] OR “Psychiatric Status Rating Scales”[MeSH] OR “Psychomotor Agitation”[MeSH] OR 
“Psychotic Disorders”[MeSH] OR “Quality of Life”[MeSH] OR “Race Relations”[MeSH] OR “Risk Factors”[MeSH] 
OR “Severity of Illness Index”[MeSH] OR “Sexual behavior”[MeSH] OR “Sleep Disorders”[MeSH] OR “Social 
Behavior Disorders”[MeSH] OR “Vision Disorders”[MeSH] OR “Activities of Daily Living”[All Fields] OR “Affect”[All 
Fields] OR “Aggression”[All Fields] OR “Agitation”[All Fields] OR “Anxiety”[All Fields] OR “Appetite”[All Fields] 
OR “Behavioral Symptom”[All Fields] OR “Behavioral Symptoms”[All Fields] OR “Behavioural Symptom”[All 
Fields] OR “Behavioural Symptoms”[All Fields] OR “Chronic Disease”[All Fields] OR “Chronic illness”[All Fields] 
OR “Cognition Disorder”[All Fields] OR “Cognition Disorders”[All Fields] OR “Communication”[All Fields] OR 
“Cooperative Behavior”[All Fields] OR “Cooperative Behaviour”[All Fields] OR “Delusions”[All Fields] OR 
“Depression”[All Fields] OR “Depressive Disorder”[All Fields] OR “Depressive Disorders”[All Fields] OR “Eating 
Disorder”[All Fields] OR “Eating Disorders”[All Fields] OR “Environment”[All Fields] OR “Euphoria”[All Fields] 
OR “Geriatric Assessment”[All Fields] OR “Geriatric Psychiatry”[All Fields] OR “Hallucinations”[All Fields] 
OR “Hearing”[All Fields] OR “Irritable Mood”[All Fields] OR “Language Disorder”[All Fields] OR “Language 
Disorders”[All Fields] OR “Marital Status”[All Fields] OR “Mental Disorder”[All Fields] OR “Mental Disorders”[All 
Fields] OR “Mood Disorder”[All Fields] OR “Mood Disorders”[All Fields] OR “Natural History”[All Fields] OR 
“Neurobehavioral Manifestation”[All Fields] OR “Neurobehavioral Manifestations”[All Fields] OR “Neurobe-
havioural Manifestation”[All Fields] OR “Neurobehavioural Manifestations”[All Fields] OR “Neuropsychological 
Tests”[All Fields] OR “Neuropsychology”[All Fields] OR “Pain”[All Fields] OR “Personality”[All Fields] OR “Psy-
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chiatric Status Rating Scales”[All Fields] OR “Psychomotor Agitation”[All Fields] OR “Psychotic Disorder”[All 
Fields] OR “Psychotic Disorders”[All Fields] OR “Quality of Life”[All Fields] OR “Race Relations”[All Fields] OR 
“Risk Factors”[All Fields] OR “Severity of Illness Index”[All Fields] OR “Sexual Behavior”[All Fields] OR “Sexual 
Behaviour”[All Fields] OR “Social Behavior Disorder”[All Fields] OR “Social Behavior Disorders”[All Fields] OR 
“Social Behaviour Disorder”[All Fields] OR “Social Behaviour Disorders”[All Fields] OR “Sleep Disorder”[All 
Fields] OR “Sleep Disorders”[All Fields] OR “Vision”[All Fields])
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abstract
background
Neuropsychiatric symptoms (NPS) frequently occur in community-dwelling patients with 
dementia and they are also frequently prescribed psychotropic drugs. The prescription of 
psychotropic drugs has been found to be associated with the level of NPS. Data on NPS in 
patients with dementia in general practices are scarce.
Objectives
The aim of this study was to assess the prevalence rates of NPS and psychotropic drug use in 
patients with dementia in general practices.
methods
We analyzed data from the baseline measurement of a prospective cohort study in a sample 
of (Dutch) patients in general practices. Prevalence rates of NPS and subsyndromes assessed 
with the Neuropsychiatric Inventory (NPI) and of psychotropic drug use were calculated. 
Prevalence rates of individual NPS are presented both as clinically relevant symptoms (NPI 
symptom score ≥ 4) and as prevalence rates of symptoms with symptom score > 0.
Results
Of the 117 patients, more than 90 % had at least one symptom and more than 65 % had at 
least one clinically relevant symptom. The most common NPS were agitation/aggression, 
dysphoria/depression and irritability/lability. The most common clinically relevant NPS were 
aberrant motor behaviour, agitation/aggression and apathy/indifference. Only 28.7 % of the 
patients used at least one, 7.0 % used at least two different and 1.7 % used at least three 
different types of psychotropic drugs (excluding anti-dementia medication).
Conclusions
NPS are highly prevalent in patients with dementia in general practices, but psychotropic 
drug use is rather low. The most common clinically relevant NPS were aberrant motor be-
haviour, agitation/aggression and apathy/indifference.
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introDuction
Dementia is a syndrome that affects memory, thinking, behaviour and the ability to perform 
everyday activities.1 Most people with dementia reside in the community. In the Netherlands, 
it is estimated that there are 260.000 people with dementia of whom approximately 70 % 
are community-dwelling i.e., not live in a long-term care facility (LTCF). Of these, 60 % live 
with their informal caregiver and 40 % alone.2,3. Over the course of the disease most of them 
will experience some type of neuropsychiatric symptoms (NPS).4 NPS include psychiatric and 
behavioural symptoms, such as delusions, hallucinations, depressive symptoms, anxiety, 
euphoria, agitation, aggression, apathy, and disinhibition.
Recent studies in various countries reported NPS prevalence rates for community-dwelling 
people with dementia that ranged from 44 % to 96 % measured with the Neuropsychiatric 
Inventory (NPI).5-21 Apathy, agitation/aggression, dysphoria/depression, irritability/lability, 
anxiety and aberrant motor behaviour were the most common NPS.5-11,13-16 Prevalence rates 
of clinically relevant symptoms (NPI symptom score ≥ 4) are lower: 44 % to 81 %, compared 
to NPI symptom score > 0: 88 % to 96 %.5-11
Half of the former studies conducted on NPS in community-dwelling people with dementia 
were community-based studies, but the number of people who were living at home versus 
those living in a LTCF were either not given or up to one-third appeared to be living in a 
LTCF. The other half of the studies were conducted on ambulatory patients with dementia 
visiting outpatient memory, (old age) psychiatry, neurological and geriatric clinical centres or 
dementia services, which is considered secondary care. Three to 36 % of these study popula-
tions also lived in a LTCF. In the Netherlands, general practitioners (GPs) provide basic medical 
care for people who live at home. For LTCF there are specifically trained medical doctors 
called elderly care physicians.22,23 Only a small proportion of people in general practice in 
the Netherlands are referred to secondary care. Therefore, it is likely that a study population 
visiting outpatient clinical centres have more severe and frequent symptoms than the total 
group of people with dementia in general practices. For GPs, it is important that accurate 
data of NPS of patients with dementia in general practices are available. To date only one 
German study reported prevalence rates of NPS in general practices.11,13
Psychotropic drugs, such as antipsychotics, are frequently prescribed in patients with 
dementia with agitation, psychosis and anxiety. The prevalence of psychotropic drug use is 
related to the prevalence of NPS.11,24 Almost 66 % of the people with dementia in primary 
care in Germany use at least one psychotropic drug and the use of antipsychotics is associ-
ated with higher NPI scores.11 In Finland 53 % of the people with dementia use at least one 
and 20 % use at least two psychotropic drugs with a prevalence rate of antipsychotic use of 
20 - 22 %.24,25 There is only limited evidence for the effectiveness of psychotropic drugs in 
the treatment of NPS in people with dementia and psychotropic drugs cause serious adverse 
effects, like extrapyramidal symptoms, accelerated cognitive decline, stroke and death. 
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Only some atypical antipsychotic drugs have shown benefit in the treatment of aggression 
in people with Alzheimer’s disease over a period of up to 12 weeks.26 Selective serotonin 
re-uptake inhibitors or serotonin-specific reuptake inhibitors (SSRIs) have been proposed 
as an alternative pharmacological approach to antipsychotics based on evidence that the 
serotonergic system is involved in the etiology of NPS in dementia.27 For example citalopram 
compared with placebo significantly reduces agitation and caregiver distress. However, 
cognitive and cardiac adverse effects of citalopram may also limit its practical application.28
NPS, especially depression, are predictors of institutionalization.29,30 They are also associ-
ated with psychological distress in informal caregivers.31-34
To date, only one study reported prevalence rates of NPS and psychotropic drug use in 
general practices. The DelpHi-MV study, a cohort study in general practices in Germany, 
found that 43.8 % of the patients had one or more clinically relevant NPS in the previous 4 
weeks and almost 66 % of the study population used at least one psychotropic drug including 
anti-dementia medication.11,13 Thus, data are scarce while they are very relevant for general 
practices, because the general practitioner (GP) is most often the first physician consulted 
for dementia-related problems and NPS frequently lead to institutionalization, high rates of 
psychotropic drug use and psychological distress in their informal caregivers.
Therefore, the aim of this study was to assess the prevalence of NPS and the prevalence of 
psychotropic drug use in patients with dementia in general practices.
methoDs
This is a cross-sectional analysis of baseline measurements from a prospective naturalistic 
cohort study with a follow-up of 18 months. All participants were living at home and cared 
for by an informal caregiver. This study has been described in detail previously.35 We invited 
all 192 known GPs in 114 general practices in the region West- and Middle-Brabant. These 
practices are representative for the Dutch general practices because the practice/GP ratio 
in West- and Middle-Brabant (59 %) is comparable to the ratio of the Netherlands (58 %).36 
Eventually, 37 GPs in 18 general practices participated in this study. These 18 general practices 
in the study are representative for the Dutch general practices because the percentages 
of single-handed/two-person/group practices seem to be rather comparable (22 % to 28 % 
single handed, 33 % to 39 % two-person practice, 44 % to 33 % group practice) and because 
the mean number of patients per practice is comparable (2062 versus 2200).
Patients and informal caregivers
We successively screened the 18 participating practices between January and July 2012 to 
identify and recruit dyads of patients and informal caregivers. Eligible patients were selected 
with a search in the electronic medical files. It took 7 months to visit all practices, selection was 
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done at one specific moment in time. These patients and their caregivers were approached 
by mail. The GP contacted patient or informal caregiver by telephone to stimulate participa-
tion in the study. Inclusion criteria for patients were: living at home and registered in the 
GP’s electronic medical file with a diagnosis of dementia. Dutch GPs code all diagnoses in 
their files according to the International Classification of Primary Care (ICPC).37 According to 
the ICPC dementia is coded as P70 and memory disturbance as P20. Patients living in a LTCF 
or with an estimated life expectancy of less than three months were excluded. This research 
project was presented for medical ethics review at the regional Committee on Research 
Involving Human Subjects (CMO). The committee judged that this project, according to the 
Dutch legislation, could be carried out without formal approval by the CMO. Patients, or 
their legal representatives, and caregivers gave written informed consent.
assessment instruments
Clinical characteristics of patients and informal caregivers were collected by a trained 
research assistant during an interview with the patient and the informal caregiver at their 
home. NPS of the patients were assessed with the Neuropsychiatric Inventory (NPI) ranging 
from 0 to 144.17,21,38 Based on previous studies we categorized the NPI in three behavioural 
subsyndromes: mood/apathy (depression, apathy, nighttime behaviour disturbances, and 
appetite and eating abnormalities), psychosis (delusions and hallucinations), and hyperac-
tivity (agitation, euphoria, irritability, disinhibition, and aberrant motor behaviour). Anxiety 
was regarded as a separate symptom.39 Cognition of the patient was assessed with the Mini-
Mental State Examination (MMSE) ranging from 0 to 30.40
Data about psychotropic drug use were obtained on the day of assessment during the 
interview with the patient and the informal caregiver. All drugs were classified according 
to the Anatomical Therapeutic Chemical (ATC) classification system: antipsychotics (N05A), 
antiepileptic medication (N03A), antidepressants (N06A), anxiolytics (N05B), hypnotics 
(N05C) and anti-dementia medication (N06D).41 For antipsychotics we made a distinction 
between typical/classical, (first-generation antipsychotics), and atypical, (second-generation 
antipsychotics). For antidepressants, we made a distinction between selective serotonin 
reuptake inhibitors (SSRI’s) and tricyclic antidepressants. Anti-dementia medication included 
the use of an acetylcholinesterase inhibitor (AChEI: rivastigmine and galantamine) or a N-
methyl-d-aspartate receptor antagonist (NMDAR: memantine).42
Prevalence of NPS
The prevalence of NPS was calculated by dividing the number of participants who exhibit 
NPS in the previous 4 weeks by the number of participants in our study population. Each 
symptom score of the NPI was defined by a frequency (F) times severity (S) score. Gener-
ally a symptom score of 4 or higher is considered clinically relevant.6-8 Prevalence rates of 
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individual NPS are presented both as clinically relevant symptoms (NPI symptom score ≥ 4) 
and as prevalence irrespective of clinical relevance (NPI symptom score > 0).
psychotropic drug use
The prevalence of psychotropic drugs and combinations of these were calculated by divid-
ing the number of participants who use one or more psychotropic drugs by the number of 
participants in our study population.
Data analysis
We summarized the demographic and clinical characteristics of the participants by descrip-
tives. All data were analyzed using the Statistical Package for the Social Sciences (SPSS) 23.0. 
For missing items for the NPI we used ipsative mean imputation, which substitutes the missing 
items by the mean of the remaining items within the individual.43,44 We accepted 1 missing 
item in the NPI for the NPI total score and no missing items for the NPI subsyndromes.
results
The participating general practices in our study are representative for the Netherlands for 
the types of general practices. We do not have data about characteristics such as age, gender 
and socioeconomic status of the total patient population of the participating practices. We 
have incomplete data of the age distribution in the 18 participating practices. In 10 of these 
practices the percentage of patients aged 75 and older is 22.5 %. In total 243 patients with 
 
Figure 1. Recruitment of patients with dementia in general practice (2012) 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dyads: patient and caregiver; LTCF: Long term care facility; n: number of participants 
 
 
Dyads recruited (n=243) 
Reasons for withdrawals (n=5): 
- Secondary objection 
- Unexpected death 
- Severe disease 
- Admission to a LTCF 
 
Reasons for refusal (n=119; 2 missing): 
- Burden/efforts of participating in the study is too high (n=55) 
- No interest (n=28) 
- Not applicable for me (n=7) 
- No time (n=3) 
- Other reasons: incomplete contact information, serious 
illness or death of patient or caregiver, language barrier or 
impossibility to make contact (n=26) 
Dyads included at baseline (n=117) 
figure 1. Recruitment of patients with dementia in general practice (2012)
Dyads: patient and caregiver; LTCF: Long term care facility; n: number of participants
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dementia were identified of whom 117 (48 %) were included (Figure 1). The mean age of the 
126 patients who refused (n = 121) or withdrew (n = 5) their consent was 79.2 years (SD 6.8) 
and 67 % were female. The mean age of the informal caregivers who refused or withdrew 
their consent (missing data n = 31) was 66.0 years (SD 14.0, range 28 - 92) and 67 % were 
female (missing data n = 2). The relation of the informal caregiver with the patient (missing 
data n = 4) was 49 % spouse, 45 % child and 6 % others. The 126 patients who refused or 
withdrew their consent were more often female; informal caregivers of these patients were 
more often child. Two patients were admitted to a LTCF after informed consent and just 
before baseline assessment. They entered the study and the baseline questionnaires were 
filled out as before institutionalization.
Clinical characteristics of the patients and informal caregivers
Patients of the study population had a mean age of 78.6 years (SD 7.1) and 52 % were female 
(Table 1). Only 4 % of these patients had an age less than 65 years. Mean NPI total score was 
low (15.7, range 0 - 77). Use of health care services were: case manager (29.3 %), day care 
centres (34.2 %), home care services (47.9 %) and domestic care (47.9 %).
Informal caregivers of the patients had a mean age of 67.3 years (SD 13.3, range 32 - 92) 
and 68.4 % were female, 65.0 % were spouse, 29.1 % child or child-in-law and 5.9 % were 
others, like grandchild, sibling, friend/acquaintance, neighbor or nephew or niece.
Prevalence of NPS
Almost all patients (92.2 %) had one or more NPS, whereas 65.5 % had one or more clinically 
relevant NPS. Prevalence rates of NPS are presented in Figure 2. The most common NPS (NPI 
symptom score > 0) were agitation/aggression (54.3 %), dysphoria/depression (52.6 %) and 
irritability/lability (48.3 %). The most common clinically relevant NPS (NPI symptom score 
≥ 4) were aberrant motor behaviour (28.4 %), agitation/aggression (23.3 %) and apathy/
indifference (21.6 %). Prevalence rates of NPI subsyndromes for NPI symptom score > 0 and 
clinically relevant NPS were: mood/apathy 81.0 % and 47.0 %, psychosis 23.3 % and 9.6 %, 
hyperactivity 80.2 % and 48.7 %, respectively.
psychotropic drug use
Prevalence rates of psychotropic drug use are presented in Table 1. Almost half (47.0 %, n 
= 54) of the patients in our study population did not use psychotropic drugs at all, 53.0 % 
(n = 61) used at least one, 13.9 % (n = 16) used at least two and four patients (3.5 %) used 
three different psychotropic drugs. When leaving out anti-dementia medication 71.3 % (n = 
82) used no psychotropic drugs at all, 28.7 % (n = 33) used at least one, 7.0 % (n = 8) used at 
least two different psychotropic medications and two patients (1.7 %) used three different 
psychotropic drugs. Of the six patients who used antiepileptics, one was for focal epilepsy, 
two for leg pain.
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Table 1. Characteristics of patients with dementia and informal caregivers (n = 117) in general prac-
tice (2012)
Patients Participants (n = 117) Refusals/withdrawals (n = 126)
Age (years)
Mean ± SD 78.6 ± 7.1 79.2 ± 6.8
Range 57 - 91 63 - 92
Gender (n (%)) (n = 89)
Male 56 (47.9) 42 (33.3)
Female 61 (52.1) 84 (66.7)
Race (n (%))
Caucasian 115 (98.3)
other 2 (1.7)
Level of profession (n (%))
Elementary occupation 23 (19.7)
Lower occupation 22 (18.8)
secondary profession 48 (41.0)
Higher profession 18 (15.4)
Scientific profession 6 (5.1)
Marital status (n (%))
Married 80 (68.4)
Widow 33 (28.2)
Divorced 1 (0.9)
Unmarried 3 (2.6)
Use of care services (n (%))
Case manager 34 (29.3)
Day care centres 40 (34.2)
Home care services 56 (47.9)
Domestic care 56 (47.9)
Psychotropic medication (n (%)) (n = 114)
No psychotropic medication 54 (47.0)
Antipsychotics 11 (9.6)
Typicalorclassic 5 (4.3)
Atypical 7 (6.1)
Antiepileptics 6 (5.2)
Antidepressants 20 (17.4)
Non-tricyclic/SSRIs 19 (16.5)
Tricyclic  1 (0.9)
Anxiolytics 3 (2.6)
Hypnotics 2 (2.6)
Anti-dementia 39 (33.6)
AChEI 39 (33.6)
NMDAR 2 (1.7)
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Discussion
We found that NPS are very common in people with dementia in general practices. More 
than 90 % of the study population had at least one NPS and more than 65 % had at least 
one clinically relevant NPS. The most common NPS were agitation/aggression, dysphoria/
depression and irritability/lability. The most common clinically relevant NPS were aberrant 
motor behaviour, agitation/aggression and apathy/indifference. Almost 29 % of the patients 
used at least one, 7.0 % used at least two different and 1.7 % used at least three psychotropic 
drugs (excluding anti-dementia medication).
Compared to the DelpHi-MV study, the prevalence of all symptoms of the NPI in our study 
are higher. The most common NPS in this study were dysphoria/depression 36.8 %, apathy 
32.2 %, agitation/aggression 31.0 %, which is, except for apathy, in line with the findings 
of our study.13 In the DelpHi-MV study GP practices screened patients aged 70 years and 
older for dementia and only 81 of the 176 (46 %) people with dementia in this cohort were 
Table 1. Characteristics of patients with dementia and informal caregivers (n = 117) in general practice 
(2012) (continued)
Patients Participants (n = 117) Refusals/withdrawals (n = 126)
MMSE-score (n = 97)
Mean ± SD 19.5 ± 5.6
Range (0 - 30) 0 - 27
Score 20+ (Mild) (n (%)) 63 (57.8)
Score 10 - 19 (Moderate) (n (%)) 31 (28.4)
Score 0 - 9 (Severe) (n (%)) 15 (13.8)
NPI total score (n = 116)
Mean ± SD 15.7 ± 15.4
Range (0 - 144) 0 - 77
Informal caregivers
Age (years) (n = 95)
Mean ± SD 67.3 ± 13.3 66.0 ± 14.0
Range 32 - 92 28 - 93
Gender (n (%)) (n = 124)
Male 37 (31.6) 41 (33.1)
Female 80 (68.4) 84 (66.9)
Relationship to the patient (n (%)) (n = 122)
spouse 76 (65.0) 60 (49.2)
Child/child-in-law 34 (29.1) 55 (45.1)
other 7 (5.9) 7 (5.7)
n: number of participants; SSRIs: Selective serotonin re-uptake inhibitors; AChEI: acetylcholinester-
ase inhibitor; NMDAR: N-methyl-d-aspartate receptor antagonist; MMSE: Mini-Mental State Exami-
nation; NPI: Neuropsychiatric Inventory
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already diagnosed before start of the study. Because of this under-reporting of GPs the study 
population in our study is probably in a more advanced stage of the disease. The mean 
MMSE score in our study (19.5 ± 5.6) is lower than in the DelpHi-MV study (20.87 ± 5.6).
Except for delusions and hallucinations, all other symptoms and subsyndromes on the NPI 
in our study were more prevalent than in the DelpHi-MV study. The most common clinically 
relevant symptoms in the DelpHi-MV study were apathy 15.3 %, aberrant motor behaviour 
11.4 %, anxiety 10.2 %, which is, except for anxiety in line with our findings.11 on the other 
hand, compared to the MAAstricht Study of BEhaviour in Dementia (MAASBED) study, a 
prospective Dutch study on a cohort of psychiatric-based clinics, the prevalence rates we 
found were lower for the majority of the clinically relevant symptoms and subsyndromes 
on the NPI (10 out of 15) except for agitation/aggression, disinhibition, aberrant motor 
behaviour, nighttime behaviour disturbance and the hyperactivity subsyndrome. Especially 
for delusions and hallucinations (psychosis subsyndrome), dysphoria/depression, apathy/
indifference and the mood/apathy subsyndrome our prevalence rates were much lower. 
Mean MMSE score in the MAASBED study was lower: 18.09 (4.68), as compared to our study 
as we expected in an ambulatory psychiatry-based study.10
 
Figure 2. Prevalence of neuropsychiatric symptoms in patients with dementia (n=116) in general practice (2012) 
 
Neuropsychiatric Inventory (NPI) score > 0: percentage of patients who exhibit the symptom on the NPI (n=116; 1 missing); NPI score ≥ 4: percentage 
of patients with clinically relevant score on the NPI (n=115; 2 missing); Psychosis subsyndrome: delusions and hallucinations; Hyperactivity 
subsyndrome: agitation, euphoria, disinhibition, irritability, and aberrant motor behavior; Mood/apathy subsyndrome: depression, apathy, nighttime 
behavior disturbances, and appetite and eating abnormalities 
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figure 2. Prevalence f neuropsychi ric symptom  in patients with dementia (n = 116) in general 
practice (2012)
Neuropsychiatric Inventory (NPI) score > 0: percentage who exhibit the symptom on the NPI (n = 
116); NPI score ≥ 4: percentage with clinically relevant score on the NPI (n = 115); Psychosis subsyn-
drome: delusions and hallucinations; Hyperactivity subsyndrome: agitation, euphoria, disinhibition, 
irritability, and aberrant motor behaviour; Mood/apathy subsyndrome: depression, apathy, night-
time behaviour disturbances, and appetite and eating abnormalities
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Psychotropic drug use in our study (28.7 % at least one excluding anti-dementia medica-
tion) is higher compared to the findings of the Dutch study of Hamers et al (16.0 %) in 2016. 
However, this study was conducted on people with cognitive impairment, not specifically 
with a diagnosis of dementia. And secondly, they were all supported by a case manager, 
compared to 29.3 % in our study. Psychotropic drug use including anti-dementia medication 
(53.0 % at least one) in our study is lower compared to the DelpHi-study (66 %). Use of anti-
psychotics in our study (9.6 %) is relatively low compared to the studies in Germany (10.6 to 
13.6 %), Finland (20 to 22.1 %) and the United States of America (USA) (27 %).11,13,24,25,45 only 
in Sweden the antipsychotic use is lower (4.2 %).46 The use of antiepileptics (5.2 %) in our 
study is lower than in Germany; use of antidepressants (17.4 %) is higher than in Germany 
(14.0 to 15.3 %), but lower than in Sweden (22.9 %) and Finland (28 %).11,13,25,45,46 The use of 
anxiolytics (2.6 %) and hypnotics (2.6 %) in our study is much lower than in Sweden (6.9 % 
and 13.3 % respectively).46 Use of anti-dementia medication (33.6 %) is similar to the studies 
in Germany (25.8 to 42 %) and low compared to Sweden (75.4 %), where the use of AChEI is 
recommended in the national guidelines for all people with Alzheimer’s disease.11,13,46 In this 
Swedish study it was found that patients taking an AChEI were treated with less antipsychot-
ics and anxiolytics than those not taking an AChEI. Overall, in our study psychotropic drug 
use is relatively low compared to other studies, specifically if you take into account the high 
prevalence rates of NPS we found. Dutch GPs and their guidelines are generally very reticent 
in prescribing psychotropic drugs.36
Strengths and limitations
The sample of patients and informal caregivers in this study was heterogeneous with patients 
in all stages of dementia and they were included from general practices. The participating 
general practices in our study are representative for the Dutch general practices. Data 
included psychotropic drug use.
A limitation to our study is the rather low participation of general practices (114 invited, 18 
participated) and high refusal rate of patients and informal caregivers indicating that burden 
of participating in the study is too high. Due to this there is a risk that we have studied a 
selective group of patients with relatively low levels of NPS. On the other hand, GPs of-
ten wait before diagnosing dementia which may have biased our sample towards a more 
severe spectrum of people with dementia and NPS. The difference in clinical characteristics 
between the participants and those who refused or were withdrawn, also gives a risk of 
selection bias. The percentage of patients aged over 75 in the participating general practices 
(22.5 %) is probably higher than in the Dutch general population (9.6 %).36 This overestimates 
the number of patients with dementia, NPS and psychotropic drug use compared to the 
average general practice in the Netherlands.
Finally, caregivers who experience high levels of psychological distress may score the NPS 
of the person with dementia they care for as more severe. Higher frequency of NPS is associ-
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ated with higher levels of psychological distress.34 This results in caregiver-rating bias, which 
could have affected the level of NPS to a more severe spectrum.16,47
Implications
We expected less severe and frequent NPS in patients with dementia in general practices 
compared to ambulatory patients visiting outpatient clinical centres, but this study showed 
that a high proportion of patients with dementia in general practices have at least one (clini-
cally relevant) NPS. The prevalence of psychotropic drug use in our study is low compared 
to other studies but still almost 29 % of the patients with dementia has a prescription for 
at least one psychotropic drug. The GP is often the first person to be consulted for patients 
who are worried that they may have dementia or for dementia-related problems like NPS. 
A timely diagnosis of dementia is important to be able to provide adequate post-diagnostic 
support, such as psycho-education, access to treatment and psychosocial interventions, 
peer support, advance care planning and advance directives.48 Many psychosocial interven-
tions for people with dementia and their informal caregivers have been developed in the 
last decades and they have proven to be more effective and give less adverse effects than 
prescribing psychotropic drugs.49-51 Cognitive stimulation or multicomponent interventions, 
in which cognitive stimulation is combined with reminiscence and relaxation or support, or 
behavioural interventions performed by individual work with the informal caregiver have 
been shown to be effective on NPS.49 Multicomponent interventions as cognitive stimula-
tion combined with reminiscence or physical exercise or ADL training or support have been 
shown to be effective in improving the mood of the people with dementia.49 NPS in people 
with dementia require a timely diagnosis and adequate professional support to diminish 
NPS and prevent institutionalization and psychological distress in their informal caregivers.
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abstract
background
During the course of dementia, most people develop some type of neuropsychiatric symp-
toms (NPS), which result in lower quality of life, high caregiver burden, psychotropic drug 
use and a major risk of institutionalization. Studies on NPS in people with dementia have 
been mainly conducted in clinical centres or psychiatric services.
Objectives
To investigate the course of NPS in people with dementia in primary care.
methods
Analysis of (cumulative) prevalence and incidence, persistence and resolution based on data 
collected during an assessment at home of a prospective naturalistic cohort study in primary 
care in a sample of 117 people with dementia and their informal caregivers. Subsyndromes of 
NPS were assessed with the Neuropsychiatric Inventory (NPI) and Cohen-Mansfield Agitation 
Inventory. Multivariate analyses were used to detect determinants for the course of NPS.
Results
The mean age of the people with dementia was 78.6 years and 52 % were female. Mean 
Mini-Mental State Examination total score was 19.5, mean NPI total score 15.7. The most 
prevalent clinically relevant subsyndromes of the NPI were hyperactivity and mood/apathy 
and the most prevalent individual NPS were aberrant motor behaviour (28 %), agitation/
aggression (24 %) and apathy/indifference (22 %). Of the people with dementia 72.3 % had 
one or more symptoms of the mood/apathy and 75.3 % of the hyperactivity subsyndrome.
Conclusions
GPs should be aware of NPS in people with dementia and should actively identify them 
when they visit these patients or when informal caregivers consult them. Timely diagnosing 
facilitates adequate professional care.
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introDuction
Dementia is a syndrome characterized by deterioration in memory, thinking, behaviour and 
everyday activities. Worldwide, around 47 million people have dementia, and there are 
nearly 10 million new cases every year.1 In the Netherlands, more than 260.000 people have 
dementia of whom 70 % are community-dwelling.2 Of these, 60 % live with their informal 
caregiver and 40 % alone.3 During the course of dementia most people develop some type 
of challenging behaviour, also called neuropsychiatric symptoms (NPS).4
NPS can be categorized in behavioural subsyndromes: mood/apathy, hyperactivity and 
psychosis. Mood/apathy and hyperactivity are the most common subsyndromes with delu-
sions, wandering/agitation, aberrant motor behaviour and apathy as the highest prevalent 
individual symptoms.4,5 Moreover NPS are persistent although frequency parameters vary 
considerably across studies.4 For hallucinations, delusions, paranoia, aggression, wander-
ing/agitation, aberrant motor behaviour, anxiety, irritability, disinhibition, apathy and sleep 
disturbance increasing trends in point prevalence rates at successive measurements have 
been found.4,6
Almost all studies on the course of NPS in community-dwelling people with dementia 
were conducted in ambulatory patients visiting outpatient memory, (old-age) psychiatry, 
neurological or geriatric clinical centres or dementia services.4 In these studies most partici-
pants were living at home. Some were living in long-term care facilities and some studies did 
not specify whether or not the study population was institutionalized.4,7-9
The only Dutch study on the course of NPS in community-dwelling people with dementia, 
the MAAstricht Study of BE-haviour in Dementia (MAASBED), was conducted in people with 
dementia enrolled from outpatient psychiatry-based clinics. This study found high incidence 
and prevalence rates and high persistence after 2 years.5
In the Netherlands, basic medical care for community-dwelling older people is provided by 
general practitioners (GPs). In long-term care facilities medical care is provided by specifically 
trained medical doctors called elderly care physicians.10 Only a small proportion of people 
in general practice are referred to outpatients’ memory, (old-age) psychiatry, neurological 
and geriatric clinical centres, which is considered secondary care. Therefore, it is likely that a 
study population visiting outpatient clinical centres has more severe and frequent symptoms 
than the total group of people with dementia in primary care.
The GP is most often the first physician consulted for dementia-related problems and 
has an important role in prescribing psychotropic drugs, such as antipsychotics, antidepres-
sants, anxiolytics and hypnotics.11-13 The use of antipsychotics is associated with higher NPI 
scores.11 Greater cognitive impairment, higher baseline severity of NPS and increased func-
tional impairment are associated with more NPS; the use of support services, like day and 
respite care and training courses for caregivers, are associated with less NPS over time.14-19 
Higher frequency of NPS is associated with higher levels of psychological distress in informal 
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caregivers of people with dementia. However, the evidence is not conclusive as to if some 
NPS are more stressful for informal caregivers than others.20-24
To our knowledge, prospective studies on the course of NPS have not been conducted in 
patients exclusively from general practices. Such a study would help GPs and other profes-
sionals in primary care in the management of their patients with dementia, especially with 
respect to the planning of follow-up visits and the timing of psycho-education, psychosocial 
interventions and the provision of care. Therefore, the aim of this study was to investigate 
the course of NPS and to detect determinants for the course of NPS in people with dementia 
in primary care.
methoDs
This is a prospective naturalistic cohort study in primary care in the southern part of the 
Netherlands with a follow-up of 18 months. All participants were living at home and cared 
for by an informal caregiver at the start of this study. All 192 known GPs in 114 general 
practices were invited of whom 37 GPs in 18 general practices participated. Patients were 
assessed at baseline and after 9 and 18 months. Follow-up was continued after admission to 
a long-term care facility. Details of this study have been described previously.21,25,26 a trained 
research assistant collected data during an interview with patient and informal caregiver at 
home at baseline (T0), at 9 months (T1) and at 18 months (T2)
Patients and informal caregivers
The electronic medical files of the 18 participating practices were screened between January 
and July 2012. We identified and recruited dyads of patients with a diagnosis of dementia 
and their informal caregivers. Patients living in a long-term care facility or with an estimated 
life expectancy of less than 3 months were excluded. Patients, or their legal representa-
tives, and caregivers gave written informed consent. The regional Committee on Research 
Involving Human Subjects in the Netherlands judged that this project could be carried out 
without formal approval.
assessment instruments
Information about age and gender of the patient, about caregivers’ age, gender and relation 
to the patient and about the use of health care services such as day care services, home and 
domestic care services and case management was collected.27
NPS of the patient were assessed with the Neuropsychiatric Inventory (NPI) and the Cohen-
Mansfield Agitation Inventory (CMAI). The NPI consists of 12 categories of NPS: delusions, 
hallucinations, agitation/aggression, depression, anxiety, euphoria, disinhibition, irritability/
lability, apathy, aberrant motor activity, sleeping disorder and eating disorder. Based on 
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previous studies we categorized the NPI in three behavioural subsyndromes, relevant for the 
GP: mood/apathy (depression, apathy, nighttime behaviour disturbances, and appetite and 
eating abnormalities), psychosis (delusions and hallucinations), and hyperactivity (agitation, 
euphoria, irritability, disinhibition, and aberrant motor behaviour). Anxiety is regarded as a 
separate symptom.28 For each individual symptom, the severity and frequency are scored 
with structured questions administered to the patients’ caregiver. The final score for each 
symptom is obtained by multiplying severity (score: 1 - 3) with frequency (score: 1 - 4). 
Symptom scores are combined to an overall score with a range of 0 to 144 with higher scores 
indicating a more severe symptom burden. In line with previous studies, a score greater than 
3 for an individual symptom was defined as clinically relevant.5,29-31
The CMAI was developed to assess the frequency of agitated behaviours. It has 29 items 
scored on a 7-point frequency scale (1 = never, 2 = < once a week, 3 = 1 - 2 times per week, 4 = 
several times per week, 5 = 1 - 2 times per day, 6 = several times per day, and 7 = several times 
per hour). Symptom scores are combined to an overall score with a range of 29 to 203 with 
higher scores indicating a more severe symptom burden.32-34 In line with a previous study we 
categorized the items in three subsyndromes: physically aggressive (spitting, cursing/verbal 
aggression, hitting, grabbing, pushing, strange noises, screaming and scratching), physically 
non-aggressive (pace/aimless wandering, inappropriate dressing/disrobing, trying to get to 
a different place, handling things inappropriately, hiding things, hoarding things and general 
restlessness) and verbally agitated behaviour (constant unwarranted request for attention/
help, repetitive sentences/questions, complaining and negativism).34 A score ≥ 3 was defined 
as clinically relevant.34
Cognition of the patient was assessed with the Mini-Mental State Examination (MMSE) 
ranging from 0 to 30.35
Psychotropic drug use of the patient was classified according to the Anatomical Therapeutic 
Chemical classification system: antipsychotics (N05A), antiepileptic medication (N03A), 
antidepressants (N06A), anxiolytics (N05B), hypnotics (N05C) and anti-dementia medication 
(N06D).36
For the assessment of psychological distress of the informal caregivers the Sense of 
Competence Questionnaire (SCQ) was used (range 27 - 135), a 27-item questionnaire of 
which higher scores indicate lower feelings of burden.37,38
Fourteen of the 18 general practices participated in a special care program called 
CONCERN (Care Optimization for Non-professional Caregivers of Elderly with dementia and 
Reduction of Neuropsychiatric symptoms) after baseline measurements. In CONCERN a GP, 
case manager and an elderly care physician systematically collaborate to improve dementia 
care in order to reduce NPS.25 Other participants received care as usual.
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Data analysis
Data were analysed using the Statistical Package for Social Science 23.0. We used descriptive 
statistics for data at T0, T1 and T2. Analysis of variance, Chi Square tests and t-tests were 
used to analyse differences between patient and caregiver dyads who completed the study 
and those who were lost to follow-up, and between patients with and without admission to 
a long-term care facility during follow-up.
We made 3 categories for cognition of the patient: 0 - 9, 10 - 19 and 20 - 30. Six patients 
had no MMSE in all 3 assessments because assessment was too stressful or because of 
absence due to stay at day care centres. It was assumed for these patients to have a low 
MMSE score 0 - 9, because they visited day care centres and used home care services and 
4 of these patients were admitted to a long-term care facility after baseline and before T1 
measurements. Eight patients were lost to follow-up. Therefore, at baseline the numbers of 
patients in the different subgroups were: MMSE score 0 - 9; n = 15 (13.8 %); score 10 - 19; n 
= 31 (28.4 %); score 20+; n = 63 (57.8 %).
The prevalence (point and cumulative), cumulative incidence, and persistence of each NPS 
at each assessment were expressed as the percentage of patients with scores greater than 
3 on any item of the NPI or subsyndrome. Pointprevalence was defined as the proportion 
of patients with a specific NPS at each assessment, cumulativeprevalence as the proportion 
of patients developing a specific NPS on at least one assessment, cumulativeincidence as 
the proportion of patients who were symptom-free at baseline but developed the specific 
NPS at subsequent assessments, persistence as a NPS present on at least 2 or during all 3 
subsequent assessments, regardless of time of first manifestation of the NPS and resolution 
as the proportion of patients who showed a specific symptom at baseline but not at the next 
assessments.5
We used a random intercept mixed model in the multivariate analysis which took into 
account the clustering of measurements within patients and the clustering of patients 
within a general practice. Dependent variables were NPI total score and the NPI and CMAI 
subsyndromes. Independent variables were patients’ age and gender, cognition of the 
patient, psychotropic drug use, patient-caregiver relationship, psychological distress of 
informal caregiver, use of respite care or personal health care at baseline and participation 
in CONCERN, all at baseline.
To investigate the course of NPS over time, a model with time as a discrete independent 
variable was used. We compared a model with interaction terms of the independent vari-
ables with time (model 2) with a restricted model without those interaction terms (model 1) 
using a likelihood ratio test.39
97
The course of neuropsychiatric symptoms in patients with dementia in primary care
results
In the 18 participating general practices 243 patients with dementia were identified of whom 
117 (48 %) were included (Figure 1). In total 32 dyads (27.4 %) were lost to follow up during 
the study: 19 dyads (16.2 %) between T0 and T1 and 13 dyads (11.1 %) between T1 and T2. 
Twenty-one patients were admitted to a LTCF between T0 and T1 and 4 patients between T1 
and T2. Of these 25 admitted patients, 15 completed the study.
 
 
 
 
 
Dyads: patient and caregiver; LTCF: Long term care facility; n: number of participants; T0: baseline; T1: after 9 months; T2: 
after 18 months.  
Dyads included at T0 (n=117)
Follow-up at T1 (n=98):
- Living at home (n=81)
- Living in LTCF  (n=17)
Follow-up at T2 (n=85):
- Living at home (n=70)
- Living in LTCF (n=15) 
Reasons for lost to follow-up (n=13):
- Death (n=11)
- Refusal  (n=2)
Reasons for lost to follow-up (n=19):
- Death (n=7)
- Refusal  (n=11)
- Admission to a LTCF (n=1)
Figure 1. Recruitment of patients with dementia in primary care and follow-up (2012 and 2013). 
figure 1. Recruitment of patients with dementia in primary care and follow-up (2012 and 2013).doc
Dyads: patient and caregiver; LTCF: Long term care facility; n: number of participants; T0: baseline; 
T1: after 9 months; T2: after 18 months.
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Characteristics of study population
Characteristics of patients and informal caregivers at baseline and separately for the patients 
who were lost to follow-up or institutionalized during follow-up are presented in Table 1 
according as the patients who refused to participate or were withdrawn. Only 4 % of the 
patients were younger than 65 years. Mean MMSE total score: at baseline 19.5 (SD 5.6; n = 
97), after 9 months 19.6 (SD 6.9; n = 70) and after 18 months 15.1 (SD 9.4; n = 63). Mean NPI 
total score: at baseline 15.7 (SD 15.4; n = 116), after 9 months 17.8 (SD 16.7; n = 97) and after 
18 months 20.3 (SD 15.6; n = 85).
course of nps
At baseline, aberrant motor behaviour (28.4 %), agitation/aggression (23.9 %) and apathy/
indifference (22.4 %) were the most prevalent clinically relevant symptoms, and their preva-
lence continued to be high or increased throughout the study (Table 2). Irritability/lability 
prevalence increased throughout the study. Delusions, disinhibition, euphoria/elation and 
hallucinations were infrequent.
Mood/apathy subsyndrome
The prevalence of the mood/apathy subsyndrome was stable throughout the study. Of the 
participants with dementia 72.3 % had one or more symptom. The high cumulative preva-
lence could be largely attributed to the symptom apathy/indifference (51.2 %). The cumula-
tive incidence was 47.7 % for the mood/apathy subsyndrome and 38.8 % for the symptom 
apathy/indifference.
Hyperactivity subsyndrome
Hyperactivity was the most prevalent subsyndrome at each measurement and increased 
throughout the study. Of the participants with dementia 75.3 % had one or more symptom. 
The high cumulative prevalence could be largely attributed to the symptom aberrant motor 
behaviour (58.8 %). The cumulative incidence was highest for the subsyndrome hyperactivity 
(55.3 %), and in particular for aberrant motor behaviour (47.0 %).
Psychosis subsyndrome
Of the psychosis subsyndrome 23.5 % of the participants with dementia had one or more 
symptoms throughout the study.
Persistence and resolution of NPI subsyndromes
Participants with dementia who had one or more symptoms of the hyperactivity or mood/
apathy subsyndrome on one assessment were highly likely to still have symptoms at the next 
assessment. Of the 85 participants with a complete follow-up, 24.7 % demonstrated at least 
one or more clinically relevant symptom of the hyperactivity subsyndrome and 20.0 % of the 
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mood/apathy subsyndrome at all assessments. Aberrant motor behaviour (22.4 %) and apa-
thy/indifference (21.2 %) showed the highest persistence for two consecutive measurements.
Euphoria/elation (80.0 %) and disinhibition (66.7 %) are the clinically relevant symptoms of 
the hyperactivity subsyndrome which are most likely to be present at baseline but not at the 
next two assessments. For the mood/apathy subsyndrome these symptoms are dysphoria/
depression (42.9 %) and apathy/indifference (41.2 %) and for the psychosis subsyndrome 
it is delusions (42.9 %). The symptom anxiety (40.0 %) is also likely to be present at one 
measurement but not at the next two assessments.
CMAI subsyndromes
Verbally agitated subsyndrome was the most prevalent subsyndrome of the CMAI at each 
measurement and remained stable throughout the study. The prevalence rates of symp-
toms of the physically aggressive and non-aggressive subsyndromes of the CMAI increased 
between 9 and 18 months of follow-up. Throughout the study 88.0 % of the participants with 
dementia had one or more verbally agitated symptoms, 82.9 % one or more symptoms of 
the physically non-aggressive subsyndrome compared to 49.6 % of the physically aggressive 
subsyndrome. For the CMAI the cumulative incidence was highest for the verbally agitated 
subsyndrome (63.3 %), but the cumulative incidence for the physically non-aggressive sub-
syndrome was almost as high (58.1 %). Participants with dementia who had one or more 
symptoms of the physically non-aggressive subsyndrome of the CMAI at baseline were 
highly likely to have symptoms again at the next two assessments (69.4 %). This was also high 
for the verbally agitated subsyndrome (48.2 %) and the physically aggressive subsyndrome 
(38.8 %). The symptoms of the physically aggressive subsyndrome of the CMAI were most 
likely to be present at baseline but not at the next two assessments.
Multivariate analysis of determinants
The majority of the multivariate analysis of determinants did not show statistically signifi-
cant results. For the NPI subsyndrome mood/apathy, we found a significant different course 
in time for cognition of the patient (p = 0.02), participation in CONCERN (p = 0.005) and for 
respite care (p = 0.002) and for the CMAI subsyndrome physically aggressive behaviour for 
relationship of the informal caregiver to the patient (p = 0.000). All results are shown in Table 
S1 and Figure S1, available as supplementary material.
Discussion
In this prospective naturalistic cohort study in primary care, we found that 72.3 % of the par-
ticipants with dementia had one or more symptoms of the NPI mood/apathy subsyndrome 
and 75.3 % of the hyperactivity subsyndrome. Almost 50 % of the participants with dementia 
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without one or more symptoms of the mood/apathy and hyperactivity subsyndrome at base-
line measurements developed these at subsequent measurements. The symptoms aberrant 
motor behaviour, apathy/indifference and in a slightly lesser degree agitation/aggression 
occurred frequently and were persistent. Most participants with dementia remained free of 
symptoms of the psychosis subsyndrome. Euphoria/elation, disinhibition, dysphoria/depres-
sion, apathy/indifference, delusions and anxiety are the symptoms that are most likely to 
resolve. The verbally agitated subsyndrome was the most prevalent subsyndrome of the 
CMAI, 88.0 % of the people with dementia had one or more verbally agitated symptoms and 
82.9 % one or more physically non-aggressive symptoms. We found a different course in time 
for participation in CONCERN for the NPI subsyndrome mood/apathy specifically between 
baseline and after 9 months of follow-up, but in our opinion it is not possible to differentiate 
the relevance of this in clinical practice.
Comparison with the literature
Except for delusions, the most prevalent individual symptoms in our study were aberrant 
motor behaviour, apathy/indifference and agitation/aggression with increasing point preva-
lence rates, which is in accordance with former studies.4
This study confirms our hypothesis that a study population visiting outpatient clinical 
centres in the Netherlands have more severe and frequent symptoms than the total group 
of people with dementia in primary care. In the Dutch MAASBED study there was a higher 
occurrence of all subsyndromes, but the most prevalent and incident symptoms were similar.5
Individual clinically relevant NPS in community-dwelling people with dementia in Australian 
Memory Clinics and in the DelpHi-Study (Dementia: life- and person-centered help) were 
less prevalent than among people with dementia in primary care in our study. This is prob-
ably a selection issue as the Australian study population partly consisted of people with mild 
cognitive impairment6 and in the DelpHi-Study after screening only 46 % of the people with 
dementia had a diagnosis of dementia before the start of the study.40
Strengths and limitations
In this study patients and informal caregivers were included from general practices. The 
sample was heterogeneous with patients in all stages of dementia. Dyads were followed 
beyond admission to a long-term care facility. The lost to follow-up rate during 18 months 
was low.
Limitations of our study are the rather low participation of general practices (114 in-
vited, 18 participated) and the difference between the participants and non-participants 
which indicates selection bias. Moreover, general practices and dyads who participated in 
CONCERN are different from those who did not and this also might result in selection bias. 
This might affect the prevalence, incidence and persistence of symptoms. Another limitation 
is that there are three assessments during the follow-up period of 18 months. Variations in 
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NPS between two successive assessments are unknown. Finally, there were missing data for 
the MMSE at baseline. We assumed that 6 patients without MMSE scores in all 3 measure-
ments have low MMSE scores (0 - 9) because they visited day care centres and used home 
care services and four of these patients were admitted to a LTCF after baseline and before T1 
measurements. This may have led to misclassification bias.
For the CMAI we categorized the items in three subsyndromes in line with a previous 
study in Dutch nursing homes, because our study population was too small to perform a fac-
tor analysis. We assumed that the factor structure would be the same for our Dutch primary 
care population.
Implications
The results of this study showed that NPS of the subsyndromes hyperactivity and mood/
apathy, and specifically aberrant motor behaviour, apathy/indifference and agitation/
aggression, are highly prevalent, incident and persistent in Dutch people with dementia in 
primary care. NPS are associated with psychological distress in informal caregivers of people 
with dementia in primary care.
Consequently, GPs should be aware of this and should actively identify these symptoms 
when they visit these patients or when informal caregivers consult them about these patients 
or for themselves. Timely diagnosing NPS facilitates adequate professional care, that might 
either train caregivers to prevent those symptoms to deal with them in an effective way or to 
look for additional assistance. This probably enables people with dementia to remain longer 
in their own environment and reduce their informal caregivers’ psychological distress.
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npi subsyndrome mood/apathy score
Figure S1. Multivariate analysis of determinants of the course of NPS in patients with dementia in primary care (2012) 
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CMAI subsyndrome Physically aggressive behaviour score 
 
 
 
 
 
 
CMAI, Cohen-Mansfield Agitation Inventory; MMSE, Mini-mental State Examination; NPI, Neuropsychiatric Inventory; 
 NPS, neuropsychiatric symptoms; T0 = baseline measurements; T1 = after 9 months; T2 = after 18 months 
 Estimated values of NPI subsyndrome and CMAI subsyndrome scores of the random intercept mixed model with time 
 are displayed on a scale of 0 to 10. 
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abstract
background
The course of psychological distress in informal caregivers of patients with dementia has 
been investigated in longitudinal studies with conflicting outcomes.
Objectives
We investigated the course and determinants of psychological distress in informal caregivers 
of patients with dementia in primary care.
methods
In this prospective observational cohort study, data were collected at baseline, after 9 and 
18 months. We assessed cognition and neuropsychiatric symptoms (NPS) of the patient 
(Mini-Mental State Examination and Neuropsychiatric Inventory) and psychological distress 
(Sense of Competence questionnaire, Center for Epidemiological Studies Depression scale 
and General Health Questionnaire1-item version) of the informal caregivers. Determinants 
for the course of psychological distress were caregivers’ age, gender and relationship with 
the patient, patients’ cognition and NPS, participation in a care program and admission to 
long term care facilities (LTCF). With linear mixed models, the course over time for psycho-
logical distress and its determinants were explored.
Results
We included 117 informal caregivers, of whom 23.1 % had a high risk for depression and 
41.0 % were identified to be likely to have mental problems at baseline. We found a stable 
pattern of psychological distress over time. Higher frequency of NPS, informal caregivers’ age 
between 50 - 70 years and being female or spouse were associated with higher psychological 
distress. For patients who were admitted to a LTCF during the study psychological distress of 
the informal caregivers improved.
Conclusions
General practitioners should focus on NPS in patients with dementia and on caregivers’ 
psychological distress and be aware of their risk for depression and mental problems, spe-
cifically to those who are spouse, female or between 50 - 70 years of age.
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introDuction
Worldwide approximately 47.5 million people have dementia with 7.7 million new cases 
every year.1 The total number is expected to increase to 75.6 million in 2030 and almost 
triple by 2050.1 In the Netherlands there are 260.000 people with dementia of whom 
approximately 70 % live in the community. Sixty percent of them live with their informal 
caregiver and 40 % alone.2,3 In the next decades the percentage of people with dementia 
living in the community will increase due to preference of older people to remain in their 
own homes for as long as possible and the economic burden associated with residential or 
nursing home care.4
Informal caregivers are at risk for deterioration of their mental health. This psychological 
distress in informal caregivers includes feelings of burden and depressive and anxiety disor-
ders.5,6 Prevalence rates of depressive disorders range from 15 to 80 % with higher preva-
lence rates for female caregivers (38 % versus 10 %).5-7
Understanding the course and determinants of psychological distress is important to 
prevent or diminish it. The course has been investigated in some longitudinal studies with 
conflicting outcomes: increase, decrease or no changes.8-15 Most of the longitudinal studies 
were performed in cohorts of ambulatory patients visiting outpatient clinical centres.9-14 It 
is likely that these patients have more neuropsychiatric symptoms (NPS) and psychological 
distress in informal caregivers is higher.
Determinants of psychological distress have been investigated in cross-sectional studies. 
Patient characteristics associated with increased distress are NPS, decline in instrumental 
ADL (IADL) abilities, severity of cognitive impairment, (male) gender and young onset 
dementia.16-20 The association of distress with NPS differs with type of NPS and it does not 
depend on frequency and severity of NPS.21 Caregiver characteristics associated with more 
psychological distress in cross-sectional studies are (younger) age, (female) gender, (lower) 
educational level/socio-economic status, longer duration of caregiving and caregiver-patient 
relationship.16,17
Determinants of the course of psychological distress have also been investigated in longi-
tudinal studies. Higher frequency of NPS, deterioration of dementia and patients’ functional 
decline are related to an increase in psychological distress over time. NPS are the most 
significant contributors to the course of psychological distress.8-12,15,19,20 Although depres-
sion, aggression, and sleep disturbances are the most frequently identified NPS to impact 
negatively on caregivers, a wide range of NPS is associated with psychological distress and 
the evidence is not conclusive as to whether some NPS are more important than others.22 
High baseline burden, living with the patient, decline in IADL of the patient and poor mental 
health of the caregiver are caregiver characteristics associated with increasing psychological 
distress over time.8-12
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In this study, we aimed to investigate the course and determinants of psychological 
distress in informal caregivers of patients with dementia in primary care. This knowledge is 
important for the general practitioner (GP) who is most often the first physician consulted 
for dementia-related problems for both the patient and informal caregiver.
methoDs
This study was a prospective naturalistic observational cohort study with a follow-up of 18 
months. In the south of the Netherlands, 192 GPs of 114 general practices were invited to 
participate of whom 37 GPs in 18 general practices participated. Follow-up was continued 
after admission to a long-term care facility (LTCF). Detailed information of the design has 
been published elsewhere.23
Patients and informal caregivers
Patients and their informal caregivers were recruited from January until July 2012. Inclu-
sion criteria for patients were living at home and registered in the GP’s electronic medical 
system with codes of International Classification of Primary Care (ICPC) for dementia (P70) 
or memory disturbance (P20). Patients living in a LTCF or with an estimated life expectancy 
of < 3 months were excluded. Patients, or their legal representatives, and caregivers gave 
written informed consent.
assessment instruments
Baseline demographics were collected by a trained research assistant at patients’ homes at 
baseline (T0), at 9 months (T1) and 18 months (T2). Cognition and NPS of the patient were 
assessed with the Mini-Mental State Examination (MMSE) ranging from 0 to 30, and with 
Neuropsychiatric Inventory (NPI) ranging from 0 to 144. The NPI consists of 12 categories 
of NPS: delusions, hallucinations, agitation/aggression, depression, anxiety, euphoria, 
disinhibition, irritability/lability, apathy, aberrant motor activity, sleeping disorder and eating 
disorder. For each positive symptom, the severity and frequency are scored on the basis of 
structured questions administered to the patients’ caregiver. The continuous score for each 
symptom is obtained by multiplying severity (1 - 3) by frequency (1 - 4).24-27 For the assess-
ment of psychological distress the Sense of Competence Questionnaire (SCQ), the Center 
for Epidemiological Studies Depression scale (CES-D) and the Likert scoring of the General 
Health Questionnaire 12-tem version (GHQ-12) were used.28-38 For the SCQ (range 27 - 135) 
higher scores indicate lower feelings of burden; for the CES-D (range 0 - 60) and GHQ-12 
(range 0 - 36) lower scores indicate better mental health. A difference score of five points 
on the SCQ was considered clinically relevant.39 For the CES-D a score ≥ 16 is associated with 
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higher risk of depression.32,33 There are no generally accepted cut-off scores for the GHQ-12 
Likert scale (0 - 1 - 2 - 3). GHQ-12 scoring for screening (0 - 0 - 1 - 1) has a cut-off score of ≥ 2.40
Two items of the SCQ and four of CES-D worded in the positive direction were recoded.32 
For missing items we used ipsative mean imputation for the SCQ, CES-D, GHQ-12 and NPI 
and last observation carried backward for the MMSE.39,41 We accepted one missing item for 
each subscale of the SCQ42, two missing items in the CES-D (10 % missing) and GHQ-1234 and 
one missing item in the NPI (10 % missing). Therefore, we had to exclude two SCQ’s, one 
GHQ-12 and two NPI questionnaires. Six patients had no MMSE because it was too stressful 
or because of absence due to stay at day care centres. It was assumed for these patients 
to have a low MMSE score 0 - 9 because they visited day care centres and used home care 
services and four of these patients were admitted to a LTCF after baseline and before T1 
measurements. Eight patients were lost to follow-up. Therefore, at baseline the numbers of 
patients in the different subgroups were as follows: MMSE score 0 - 9; n = 15 (13.8 %); score 
10 - 19; n = 31 (28.4 %); score 20+; n = 63 (57.8 %).
Information on the use of care services, such as day care centres, home care services, 
domestic care and case management, was collected. Day care centres can provide sup-
port and activities for people with dementia and provide respite for informal caregivers. 
Home care services include personal care and health care. Domestic care includes several 
household tasks that patients may require help with. In the Netherlands (medical) care for 
community-dwelling people with dementia is primarily provided by the GP. Further help can 
be provided by a case manager (CM), which involves assessment, planning and advocacy 
for people with dementia and their informal caregivers. This is available in all parts of the 
country. In this study, in 14 of the 18 general practices, a special care program called Care 
Optimization for Non-professional Caregivers of Elderly with dementia and Reduction of 
Neuropsychiatric symptoms (CONCERN) was provided. In CONCERN a GP, CM and an elderly 
care physician systematically collaborate to improve dementia care in order to reduce NPS.23 
Participation in CONCERN was by choice of the patients and caregivers and started after 
baseline measurements. Other participants received care as usual only by the GP or also by 
a CM as single component care.
Data analysis
Data were analysed using the Statistical Package for Social Science 20.0. We used descriptive 
statistics for data at T0, T1 and T2. Analysis of variance, chi-square tests and t-tests were 
used to analyse differences between patient and caregiver (dyads) who completed the study 
and those who were lost to follow-up, and between patients with and without admission to 
a LTCF during follow-up.
To take into account the clustering of measurements within patients and the clustering of 
patients within a general practice, linear mixed models with random intercept were used. 
Dependent variables were SCQ, CES-D and GHQ-12 (psychological distress). Determinants 
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were caregivers’ age and gender, patient-caregiver relationship, NPS and patients’ cogni-
tion.8-12 Other determinants were participation in CONCERN and admission to a LTCF. No 
linear relationship was found between age of the caregiver and cognition of the patient with 
the dependent variables. Age of the caregiver was categorized in three subgroups: < 50, 
50 - 70 and > 70 years of age because the group 50 - 70 refers to the sandwich generation. 
Cognition of the patient was categorized in three subgroups each of one third cut off range 
of seriousness of the MMSE score: 0 - 9, 10 - 19 and 20 - 30.
To investigate course over time of caregiver burden a model with time as an independent 
variable was used. Interaction terms of time with patient and caregiver characteristics 
were added to the model to investigate differences in course over time of caregiver burden 
between subgroups of patients and caregiver dyads. We removed all non-significant interac-
tion terms (p > 0.05) manually using a stepwise backward selection procedure.
results
The flowchart of the study population is shown in Figure 1. The 126 patients who refused or 
were withdrawn were more often female; informal caregivers of these patients were more 
often child. Two patients, who were admitted to a LTCF after informed consent and just 
before baseline assessment entered the study and the baseline questionnaires were filled 
out for the situation as before institutionalization.
Table 1 shows patient and caregiver characteristics for patients at all measurements. The 
study population was homogenous concerning race: 98 % Caucasian and 2 % other. Patients 
lost to follow up (n = 32; 27.4 % in 18 months) were older (80.8 versus 77.8 years; p = 0.038) 
and used more care services (65.6 % versus 41.2 %; p = 0.018) at baseline than those who 
completed the study (n = 85).
Twenty-one patients were admitted to a LTCF between T0 and T1 and 4 patients between 
T1 and T2. Of these 25 patients 15 completed the study. Caregivers of patients admitted to a 
LTCF during follow-up were statistically different at baseline on relationship (p = 0.017): they 
were less often spouse (44.0 % versus 70.7 %) and more often child (52.0 % versus 22.8 %). 
SCQ mean scores were lower (92.0 versus 100.5; p = 0.033) and CES-D mean scores (16.0 
versus 9.0; p = 0.001) and GHQ-12 mean scores (15.0 versus 10.8; p < 0.001) were higher 
indicating higher psychological distress. Patients admitted to a LTCF used more home care 
services (88.0 % versus 37.0 %; p < 0.001) and had higher NPI total scores (24.2 versus 13.4; 
p < 0.001) at baseline.
Caregivers who participated in CONCERN had statistically significant lower SCQ mean 
scores at baseline (95.7 versus 101.7; p = 0.041). Patients who participated in CONCERN 
were different at baseline on gender (p = 0.033): they were more often male (57.6 % versus 
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Dyads: patient and caregiver; LTCF: Long term care facility; n: number of subjects; T0: baseline; T1: after 9 months;  
T2: after 18 months. 
Dyads recruited (n=243) 
Reasons for withdrawals (n=5): 
- Secondary objection 
- Unexpected death 
- Severe disease 
- Admission to a LTCF 
 
Reasons for refusal (n=119; 2 missing): 
- 46.2% Burden/efforts of participating in the study is too high 
- 23.5% No interest 
- 5.9%   Not applicable for me 
- 2.5%   No time 
- 21.8% Other reasons: incomplete contact information, serious 
illness or death of patient or caregiver, language barrier or 
impossibility to make contact 
Dyads included at T0 (n=117) 
Reasons for lost to follow-up (n=19): 
- Death (n=7) 
- Refusal (n=11) 
- Admission to a LTCF (n=1) 
Follow up at T1 (n=98): 
- Living at home (n=81) 
- Living in LTCF (n=17) 
 
Reasons for lost to follow-up (n=13): 
- Death (n=11) 
- Refusal (n=2) 
 
Follow up at T2 (n=85): 
- Living at home (n=70) 
- Living in LTCF (n=15) 
 
figure 1. Flowchart study population
Dyads: patient and caregiver; LTCF: Long term care facility; n: number of subjects; T0: baseline; T1: 
after 9 months; T2: after 18 months.
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37.9 %). Caregivers and patients who participated in CONCERN were less often supported by 
a CM at baseline (13.8 % versus 44.8 %; p < 0.001).
The percentage of informal caregivers with a clinically relevant difference (≥ 5) on the SCQ 
between T0-T1 was 69.0 % (n = 67). Of these informal caregivers 41.2 % (n = 40) improved 
and 27.8 % (n = 27) declined. At baseline 23.1 % (n = 27) of informal caregivers had a high 
risk for depression (CES-D score ≥ 16) and 41.0 % (n = 48) were identified to be likely to have 
mental problems (GHQ-12 screening 0 - 0 - 1 - 1 score ≥ 2).
course of scQ, ces-D and ghQ-12
The mean scores of SCQ, CES-D and GHQ-12 at each assessment for the whole group of 
dyads showed little change over time in 18 months with only a significantly improved but 
clinically not relevant SCQ score (3.4 points) between T0 and T1 (Table 2).
Multivariate analysis of determinants
Results of the multivariate analysis with linear mixed models are shown in Table 3. The first 
column of each dependent variable indicates whether there is a significant relation between 
the determinant and the dependent variable. The fixed effects estimates in the second 
column and the statistical significance in the fourth column of each dependent variable 
indicates the difference in score between the subgroup of the determinant and the refer-
ence group of the dependent variable and whether this difference is significant.
Informal caregivers’ age, gender, relationship to the patient, admission of the patient to 
LTCF and patients’ NPS were statistically significant related to psychological distress. Statisti-
cally significant and clinically relevant lower scores of SCQ and statistically significant higher 
scores of CES-D were found in informal caregivers’ age group 50 - 70 years compared to 
age group > 70 years. Statistically significant lower CES-D and GHQ-12 scores were found in 
male compared to female informal caregivers. Statistically significant and clinically relevant 
higher scores of SCQ and statistically significant lower scores of CES-D and GHQ-12 were 
found in children compared to spouses. Statistically significant and clinically relevant lower 
Table 2. Estimated marginal means of psychological distress in informal caregivers of patients with dementia 
(n = 117)
t0 t1 t2
n mean 95 % CI n mean 95 % CI
Significance 
t0-t1 n mean 95 % CI
Significance  
t0-t2
SCQ 115 98.7 96.0 - 101.5 97 102.1 99.2 - 105.0 P = 0.019 84 99.8 96.8 - 102.8 P = 0.474
Ces-D 117 10.3 8.6 - 12.1 98 9.8 7.9 - 11.6 P = 0.410 85 11.4 9.5 - 13.3 P = 0.142
GHQ-12 116 11.5 10.5 - 12.6 98 11.4 10.4 - 12.5 P = 0.864 85 12.2 11.1 - 13.3 P = 0.154
CI: confidence interval; n: number of informal caregivers; T0: baseline; T1: after 9 months; T2: after 
18 months; T0-T1: between baseline and 9 months; T0-T2: between baseline and 18 months.
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scores of SCQ and statistically significant higher scores of CES-D and GHQ-12 were found in 
informal caregivers of patients who continued to live at home during the study compared 
to informal caregivers of patients who were admitted to a LTCF during follow-up. NPI total 
score is negatively related to SCQ total score and is positively related to CES-D and GHQ-12 
total score.
Although informal caregivers’ age and relationship to the patient were significantly cor-
related (p < 0.001) the correlation coefficient was medium (Cramer’s V 0.55). Age of the 
informal caregivers and relationship to the patient both contributed to the model. This 
indicates that relationship to the patient is important in informal caregivers between 50 - 70 
years.
 After multivariate analyses entering time and an interaction of time with the other de-
terminants in the model and a stepwise backward selection procedure only the interaction 
term of gender with time remained in the model with outcome GHQ-12 (p = 0.037) indicat-
ing a different course in time for male and female (higher scores at all three assessments) 
caregivers.
Discussion
In this naturalistic prospective observational cohort study, we found a stable pattern of 
psychological distress over time among 117 informal caregivers of patients with dementia 
in primary care. Sixty-nine percent of informal caregivers had a clinically relevant difference 
score on the SCQ between T0 and T1 of which 41.2 % improved and 27.8 % declined. At 
baseline, 23.1 % of informal caregivers had a high risk for depression and 41.0 % were identi-
fied to be likely to have mental problems. NPI total score at baseline was low [15.7 standard 
deviation (SD) 15.4]. Especially compared to the Dutch MAASBED study in psychiatric-based 
clinics in which a total NPI score of 21.6 (SD 20.8) was found.43
Multivariate analysis showed that higher frequency of NPS as well as informal caregivers’ 
age, gender and relationship to the patient were associated with higher psychological dis-
tress. Female informal caregivers have higher levels of psychological distress compared to 
male informal caregivers. Informal caregivers aged 50 - 70 have higher levels of psychological 
distress compared to those aged > 70 years. Spouses have higher levels of psychological 
distress than children. Relationship to the patient is important in the informal caregivers’ age 
group 50 - 70 years. For patients who were admitted to a LTCF during the study psychologi-
cal distress of the informal caregivers improved. At baseline these informal caregivers were 
more often spouse and had higher levels of psychological distress. The patients whom they 
cared for had more NPS and used more home care services. In the multivariate model with 
an interaction of time we only found a different course over time for GHQ-12 for gender, 
which we therefore considered as a finding of coincidence.
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Mean SCQ scores in other Dutch studies with community-dwelling people differ from our 
findings. Janssen et al.31 found higher mean baseline SCQ scores of 107.7 in their population 
of 93 primary care patients with higher mean MMSE-scores (22.4). Graff44 found mean SCQ 
scores of 89.7 at baseline in the occupational therapy group and 90.4 in the control group. 
Even though in this randomized controlled trial patients with a score > 12 on the geriatric 
depression scale and with severe NPS were excluded. Janssen et al. and Graff found similar 
mean CES-D and GHQ-12 scores.31,45
The stable pattern of levels of burden that we found is in line with the 1-year follow-up 
study of Heru and the 2-year follow-up study that Berger conducted on outpatient referrals 
to a memory clinic.9,13 Berger found that severe depression decreased over time; the total 
percentage of caregivers with slight and moderate depression increased over the same 
period.9 A stable level of depressive symptoms in informal caregivers in longitudinal studies 
has also been described.46,47 Four other prospective studies in outpatients of memory and 
dementia clinics with 1- or 2-year follow-up found a (slight) increase of psychological distress 
over time.10,12,15 One other longitudinal study with a follow-up of 3 years identified three 
different groups: initially high but decreasing burden, moderate but increasing burden and 
low burden that increased slightly.11 None of the other longitudinal studies reported data on 
informal caregivers of patients with admission to a LTCF during the study.
The relation between high frequency of NPS and caregiver burden is in line with former 
longitudinal studies.9-12,15,20 In our study cognition was not a determinant for psychological 
distress, which is in line with the findings of Aguera-Ortiz and Brodaty.10,12 However, Berger9 
found a significant correlation between caregivers’ psychological distress and cognitive status 
and dementia severity. Conde-Sala and Brodaty also found a relation between informal 
caregivers’ gender and relationship to the patient and psychological distress.11,12 They also 
found that living with the patient/being spouse11 and being a female informal caregiver12 is 
related to higher psychological distress.
Strengths and limitations
Patients and informal caregivers in this study were included from general practices. It was 
a heterogeneous sample with patients in all stages of dementia and dyads were followed 
beyond admission to a LTCF. There was a low rate of lost to follow-up during 18 months.
Limitations to our study are the rather low participation of general practices (114 invited, 
18 participated), the large proportion of general practices that provide CONCERN and that 
46.2 % of the patients and informal caregivers who refused to participate indicated that 
burden/efforts of participating in the study is too high. This may have resulted in a selective 
group of informal caregivers with relatively low levels of psychological distress. However, 
caregivers who participated in CONCERN had statistically significant higher levels of psycho-
logical distress (lower SCQ mean scores) and were less often supported by a CM at baseline.
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Another limitation in our study is the difference between the participants and non-
participants. However, we do not know if other longitudinal studies on psychological distress 
also had this risk of selection bias, because none of the other studies did present the number 
of non-participants or the characteristics of them.
The lack of information on other caregiver characteristics such as the number of daily 
hours spent, the duration of caregiving and the nature of the caregiving role (sole caregiver 
or shared responsibility) is also a limitation. Informal caregivers who are spending more 
daily hours on caregiving for a longer period of time are likely to have more psychological 
distress9,11,19, whereas sharing responsibility might reduce it.11 Thirdly, there were missing 
data, especially for the MMSE at baseline. Also, the baseline characteristics of the patients 
who were lost to follow-up during the study were different from those who completed 
the study: they were older and used more care services. Both give selection bias. Finally, 
caregiver-rating bias could have affected the relationship between NPS and psychological 
distress. Caregivers who experience high levels of psychological distress may score the NPS 
of the person with dementia they care for as worse.48
Implications
The results of this and previous studies showed that in spite of low NPI total scores, NPS is 
significantly related to psychological distress. Therefore, NPS should be proactively assessed 
by the GP as well as on caregivers’ psychological distress. Specifically, to those who are 
spouse, female and between 50 - 70 years of age, which are associated with higher levels of 
psychological distress. GPs should be aware of the informal caregivers’ risk for depression 
and mental problems. The group of informal caregivers between 50 and 70 years correspond 
to the sandwich generation of people who care for their aging parents or spouse while 
supporting their own children and probably taking care of grandchildren as well. Informal 
caregivers encounter other life phase specific problems including relational difficulties, fam-
ily conflict, employment and financial issues.4 GPs should pay attention to these problems, 
especially because of the availability of effective psychological and psychosocial interven-
tions to reduce informal caregivers’ psychological distress such as education programs, 
respite care, support groups and cognitive-behavioural therapy.4,49
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general Discussion
The aim of this thesis was to investigate the prevalence of neuropsychiatric symptoms 
(NPS) and psychotropic drug use, as well as the course and determinants of NPS in people 
with dementia and the psychological distress in their informal caregivers in primary care. 
In the following, a summary of the main findings, the methodological considerations, the 
generalizability of the findings, the impact for dementia care in general practices and recom-
mendations for education and future research are discussed in more detail.
summary of the main finDings
What is known from earlier research about the prevalence and course of 
neuropsychiatric symptoms in community-dwelling people with dementia?
We conducted a systematic review in which we included 23 prospective cohort studies for 
data analysis. NPS in these studies were assessed by 15 different assessment instruments. 
Twelve studies presented data for patients per assessment, including those lost to follow-up. 
Studies showed a lot of variation concerning duration of follow-up (1 - 6 years), timing be-
tween assessments and the total number of assessments (2 - 12). Consequently, the results 
of the studies varied considerably. Overall, we found that NPS are highly prevalent, incident 
and persistent. Virtually all patients with dementia showed NPS during a period of 1 - 6 years. 
We presented the data in 3 subgroups: a subgroup with affective symptoms (mood/apathy), 
a subgroup with hyperactivity symptoms and a subgroup with psychotic symptoms. NPS in 
the affective subgroup were the most prevalent, NPS in the psychotic subgroup the least 
prevalent. On symptom level our review showed that delusions, wandering/agitation, aber-
rant motor behaviour/motor hyperactivity, and apathy were the most common. We found 
increasing point prevalence rates in consecutive assessments for hallucinations, delusions, 
paranoia, aggression, wandering/agitation, aberrant motor behaviour/motor hyperactivity, 
disinhibition, apathy and sleep disturbance in some studies and decreasing point prevalence 
rates in consecutive assessments for depression and anxiety in some other studies. There 
were a lot of similarities between the occurrence of NPS in community-dwelling people with 
dementia and those living in nursing homes, especially concerning wandering/agitation and 
apathy.
What is the prevalence of neuropsychiatric symptoms and psychotropic drug use 
in people with dementia in general practice?
Our study showed that NPS are very common in people with dementia in general practice. 
At baseline, more than 90 % of the study population had at least one NPS and 66 % had 
at least one clinically relevant (NPI symptom score ≥ 4) NPS. The most common NPS were 
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agitation/aggression, depression and irritability. The most common clinically relevant NPS 
were aberrant motor behaviour, agitation/aggression and apathy.
Fifty-three percent of the people with dementia used psychotropic medication (includ-
ing ant-dementia medication). Almost 29 % of the patients used at least one, 7 % used at 
least two different and 2 % used at least three psychotropic drugs (excluding anti-dementia 
medication). Antipsychotics were prescribed to 10 %, antidepressants to 17 % and anti-
dementia medication to 34 % of the patients.
What is the course of neuropsychiatric symptoms and which are the 
determinants for the course of neuropsychiatric symptoms in people with 
dementia in primary care?
Over a period of 18 months, our prospective study showed that in people with dementia 
several NPS, as assessed by the neuropsychiatric inventory (NPI), were highly prevalent, 
incident and persistent and that some NPS were more likely to resolve. The majority of 
people with dementia showed one or more symptoms of the mood/apathy or the hyperac-
tivity subsyndrome (72 % versus 75 %) over 18 months. For people with dementia with one 
or more symptoms at baseline, these persisted for 18 months in 20 % and 25 %, respectively. 
Approximately half of the patients with dementia without symptoms of the mood/apathy 
or hyperactivity subsyndrome at baseline developed these symptoms at subsequent mea-
surements (48 % versus 55 %). The clinically relevant symptoms aberrant motor behaviour, 
apathy and to a slightly lesser degree agitation/aggression occurred frequently in a period 
of 18 months (59 %, 51 % and 46 %) and apathy, agitation/aggression and irritability (9 %, 
9 % and 8 %) were the most persistent for at least 18 months. On the other hand, most pa-
tients with dementia remained free of symptoms of the psychosis subsyndrome. Euphoria, 
disinhibition, depression, delusions, also apathy and anxiety were the symptoms that were 
most likely to resolve during at least 18 months after baseline.
Verbally agitated symptoms, as assessed by the Cohen-Mansfield Agitation Inventory 
(CMAI), were the most prevalent over a period of 18 months, closely followed by physically 
non-aggressive symptoms (88 % versus 83 %). These symptoms were also very likely to occur 
after baseline (cumulative incidence 64 % versus 58 %) and to persist over a period of 18 
months (48 % versus 69 %)
For the course of NPS we found a different course in time for cognition of the patient, 
participation in CONCERN, use of respite care and for the relationship of the informal care-
giver to the patient. As we used a likelihood ratio test, we do not consider these results as 
a coincidence, but in our opinion, it is not possible to differentiate the relevance of this in 
clinical practice due to the small effect sizes.
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What is the course of psychological distress in informal caregivers of people with 
dementia in primary care and which are its determinants?
Our study about informal caregiver distress showed that at baseline, 23 % of informal 
caregivers of people with dementia in primary care had a high risk for depression, as as-
sessed with the Center for Epidemiological Studies Depression scale (CES-D). Forty-one 
percent scored above the cut-off score ≥ 2 indicating a high risk of psychological symptoms 
according to the General Health Questionnaire 12-item version (GHQ-12). Over a period of 
18 months the total group of these informal caregivers showed a stable pattern of psycho-
logical distress. Multivariate analysis showed that higher frequency of NPS in the people 
with dementia as well as informal caregivers’ age, gender and relationship to the patient 
were associated with higher levels of psychological distress. Higher levels of psychological 
distress were associated with being a female informal caregiver, being between 50 - 70 
years old and being a spouse. The psychological distress of the informal caregivers improved 
when the patient they cared for was admitted to a long-term care facility (LTCF) during the 
study. At baseline these informal caregivers were more often spouse and had higher levels 
of psychological distress. The patients whom they cared for had more NPS and used more 
home care services.
Caregivers’ age and gender, patient-caregiver relationship, NPS, cognition of the patient, 
participation in CONCERN and admission to a LTCF were not significantly associated with the 
course of psychological distress.
methoDological consiDerations
change of study design
This study was originally designed as a cluster randomized controlled trial (RCT). The aim 
was to test a new approach for optimization of care delivery for people living at home with 
dementia and NPS and their informal caregivers using an individually tailored, multidis-
ciplinary care program and to evaluate its effectiveness. In this care program called Care 
Optimization for Non-professional Caregivers of Elderly with dementia and Reduction of 
Neuropsychiatric symptoms (CONCERN), a general practitioner (GP), case manager and 
an elderly care physician systematically collaborate to improve the care for patients with 
dementia in order to reduce NPS. It was intended that the elderly care physician reviewed 
the diagnosis of dementia and differentiated in a specific clinical diagnosis of dementia. The 
inclusion criteria for this cluster RCT were: age 65 years or older, living at home, informal 
caregiver available, NPS being a problem for patient and/or informal caregiver (NPI-Q (sever-
ity) score > 1 and /or NPI-Q caregiver distress scale > 2 on one or more items). Patients were 
excluded when life expectancy was less than 3 months, the person with dementia was living 
in a LTCF or on a waiting list for admission to a LTCF and when a case manager was already 
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involved or when the patient and informal caregiver were already referred to secondary care 
for treatment of the NPS. Assessments were chosen at baseline and after 9 and 18 months 
to be able to implement CONCERN and to measure its effectiveness.
We included patients from the GPs’ electronic medical system with a diagnosis of demen-
tia. During inclusion, the necessary information to properly include or exclude patients with 
dementia appeared often not to be available. Subsequently, during recruitment the majority 
of the patients and/or informal caregivers declared that there were no NPS at all. And finally, 
several patients with dementia and their informal caregivers were willing to participate in 
the study but did not want the involvement of a case manager or already were attended 
by a case manager on a regular basis. Because of the prospect of not being able to include 
a sufficient number of participants in the study, we decided to change the design from a 
cluster RCT into a prospective cohort study. There were 14 general practices, of which the 
GPs already agreed to participate in this study and to implement CONCERN and we added 
4 more general practices, of which the GPs were willing to participate in this prospective 
cohort study, but not in CONCERN. Not all patients in the 14 participating practices were 
actually involved in CONCERN because participation was the choice of the patients and 
their caregivers. We did not evaluate whether CONCERN was implemented correctly in the 
general practices. In the data analysis of this prospective cohort study, we used participation 
in CONCERN as a separate variable in the multivariate analyses. For the prospective cohort 
study, the 3 chosen assessments for the original cluster RCT during the follow-up period of 
18 months is a limitation, because variations in NPS between two successive assessments 
remain unknown.
Influence of bias
Selectionbias occurs when individuals or groups in a study differ systematically from the 
population of interest.1 In general, selection bias can have varying effects, and the magnitude 
of its impact and the direction of the effect is often hard to determine.2 There are several 
sources for selection bias in our study: the rather low participation rate of general practices, 
the difference in clinical characteristics between the participants and those who refused or 
were withdrawn before the start of the study and the high refusal rate of dyads indicating 
that the burden of participating in the study is too high. The low participation rate of general 
practices could have resulted in a selection of GPs who are familiar with and interested in 
people with dementia. The consequence of this could be that patients who were consult-
ing these GPs have been appropriately assessed and diagnosed and that more people in 
a less advanced stage of dementia are denoted in the GPs’ electronic medical system.3,4 
Patients who refused or were withdrawn before start of the study were more often female 
(67 % versus 52 % of the study participants) and the relationship of the informal caregiver 
to the patient was less often spouse (49 % versus 65 % of the study participants) and more 
often child (45 % versus 29 % of the study participants). This might indicate that informal 
139
General discussion
caregivers of female patients and informal caregivers who were related to the patient as 
child experienced less motivation to participate in this study. There was also a high refusal 
rate of participants (50 %) and almost half of them indicated that burden of participating in 
the study was too high. It is difficult to determine the impact and the effect of this on our 
outcomes, because this could have biased our study population into several directions: to 
patients with less or more advanced stages of dementia and NPS and to informal caregivers 
experiencing lower or higher levels of psychological distress.5 The most important factors 
are the low participation rate of GPs and high refusal rate of dyads due to high burden for 
participation in the study. We assume that the first factor did not influence the results of our 
study because the prevalence and incidence of NPS are not dependent on whether the GP is 
interested in or well-equipped for dementia related problems. The second source for selec-
tion bias (high burden for participation in the study) probably results in an underestimation 
of prevalence and incidence of NPS in primary care.
Attrition bias occurs when there is an unequal loss to follow-up or losses of different 
types of participants from study groups.6 There is a rule of thumb for rCTs that less than 
5 % attrition leads to little bias and more than 20 % poses serious threats to validity.7 In rCTs 
expecting loss to follow-up rates are 5 to 15 % over a 1-year follow-up period.7 Loss to follow-
up is also inevitable in most cohort studies. In the past, suggested acceptable follow-up rates 
were: 50 % is adequate, 60 % is good and 70 % is very good,8 although others suggested a 
minimum acceptable follow-up rate of 80 %.9 on the other hand, when loss to follow-up is 
(completely) at random, attrition bias is unlikely to occur with levels of loss to follow-up up 
to 60 %.10 In a recent study in primary care it was also found that attrition in cohort studies 
of older people does not inevitably indicate bias.11 In our prospective cohort study, the rate 
of lost to follow-up was 16 % after 9 months and 27 % after 18 months (18 % after one year) 
of which 50 % was due to death of patient participants.12 With regard to the mean age of 
79 years and to the participation of patients with dementia with a limited life expectancy 
we consider our rate of follow-up of 73 % as acceptable. At baseline, the characteristics of 
the patients who were lost to follow-up during the study were different from those who 
completed the study: they used more home care services and were on average 2 years older. 
This might indicate that these patients were in a more advanced stage of dementia at the 
start of the study and more at risk to die over the 18-months study period. In the light of the 
high mortality rate in this population, which is to be expected, we consider the attrition rate 
in our study as acceptable and not threatening the validity of the study results.
Misclassification bias occurs when a study participant is categorized into an incorrect 
category.13 For the multivariate analyses with the linear mixed models we categorized cogni-
tion in 3 subgroups each one third cut-off range of severity of the MMSE score: 0 - 9, 10 - 19 
and 20 - 30. Six patients had a missing MMSE in all 3 measurements, because it was too 
stressful or because of absence due to stay at day care centres during the interview. We 
assumed for these 6 patients to have a low MMSE score 0 - 9 because they visited day care 
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centres and used home care services and 4 of these patients were admitted to a LTCF after 
baseline and before T1 measurements. This may have led to misclassification bias, but our 
assumption is an example of the use of a worst-case scenario, which is partly underlined by 
the facts that these patients visited day care centres and used home care services and that 
4 of these patients were admitted to a LTCF after baseline and before T1 measurements. It is 
possible that the worst-case scenario has led to exaggerated estimations of prevalence and 
incidence of NPS in the category MMSE score 0 - 9, but we assume that the precise influence 
of this bias is minimal.
Caregiver-rating bias occurs when caregivers who experience high levels of psychologi-
cal distress themselves score the NPS of the person with dementia they care for as more 
severe.14 It is to be expected that more NPS are associated with higher levels of psychological 
distress in their informal caregivers, but the effect of caregiver rating bias is that the associa-
tion is stronger. Thus, the caregiver-rating bias could have resulted in an overestimation of 
the prevalence of NPS.14,15 Our data based on informal caregiver ratings should therefore be 
interpreted with a little caution. An alternative for informal caregiver rating is observation by 
a research assistant. The NPI warrant collecting information on NPS in the previous 4 weeks. 
Observation would be very time-consuming and expensive in the accomplishment of such 
assessments. So, we have to accept the potential caregiver-rating bias in our study.
Inconclusion, we consider the high refusal rate of dyads indicating that the burden of par-
ticipating in the study was too high as the most important bias. As a result - and considering 
all sources of bias together - we assume that our prevalence and incidence rates are an 
underestimation of the caregiver-ratings of NPS in primary care.
Generalizability to other general practices
All patients in our study population were registered in the GPs’ electronic medical file 
with a diagnosis of dementia.16 GPs often wait before diagnosing dementia, although an 
in-home geriatric primary care intervention can help to identify dementia in relatively early 
stages.3 In various Western countries only 20 to 50 % of people with dementia have a formal 
diagnosis3,17-23; in the Netherlands this is 25 %.3
This study was performed in the southern part of the Netherlands. Although the sample of 
GPs is representative for the average Dutch general practice concerning the number of the 
GPs and mean number of patients per practice its generalizability is questionable because of 
the participation in CONCERN for the majority (14 out of 18) of the general practices. Data 
on the age distribution of the patient population in the participating general practices indi-
cate that the percentage of patients aged 75 and older (23 %) is higher in the participating 
general practices than in the general Dutch population (10 %). This may also overestimate 
the number of patients with dementia, NPS and psychotropic drug use compared to the 
average general practice in the Netherlands, as these practices might be more organized in 
assessing elderly patients and in particular people with dementia .24
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Finally, the results of this study are only generalizable to other countries with a similar 
primary care system (gate-keepers and general coordinators of primary care) like Great 
Britain and Denmark.25,26
Comparability with other studies
As far as we know, there is only one other study on people with dementia and NPS with a 
study population that has been recruited from general practices.27 From this longitudinal 
study in Germany only cross-sectional data have been published. Compared to this study, 
the prevalence of all symptoms of the NPI in our study are higher. The most common NPS 
in the German study were depression (37 %), apathy (32 %) and agitation/aggression (31 %), 
which is, except for apathy, in line with the findings of our study (agitation/aggression 54 %, 
depression 53 % and irritability 48 %).27 Concerning apathy (41 %) our study shows that after 
aberrant motor behaviour (47 %), together with anxiety (41 %) it is the fifth prevalent indi-
vidual symptom. For the most common clinically relevant symptoms (NPI symptom score ≥ 
4) the findings in Germany were: apathy (20 %), aberrant motor behaviour (15 %) and anxiety 
and appetite and eating change (both 13 %). The prevalence of agitation/aggression (12 %) 
is low compared to our results: aberrant motor behaviour 29 %, agitation/aggression 23 % 
and apathy 22 %. In the German study, GPs started with screening patients aged 70 years 
and older for dementia and only 109 of the 248 (44 %) people with dementia in this cohort 
had already been diagnosed before start of the study. Therefore, the study population of 
the German study probably contained more people with a slightly less advanced stage of 
dementia (mean MMSE score in our study (19.5 ± 5.6) compared to the German study (20.9 
± 5.6)) and consequently could have lower prevalence rates of NPS.
On the other hand, compared to a prospective Dutch study on a cohort of psychiatric-
based clinics (MAASBED) the prevalence rates in our study were lower for the majority of the 
clinically relevant symptoms and subsyndromes on the NPI (10 out of 15), except for agita-
tion/aggression, disinhibition, aberrant motor behaviour, night-time behaviour disturbance 
and the hyperactivity subsyndrome.28 Our prevalence rates were much lower, especially 
for delusions and hallucinations (psychosis subsyndrome), dysphoria/depression, apathy/
indifference and the mood/apathy subsyndrome.28 In the MAASBED study dementia was 
in a slightly more advanced stage (lower MMSE scores 18.0 ± 4.7) and, as we expected in a 
cohort of psychiatry-based clinics, there was a higher prevalence, incidence and persistence 
of NPS in all subsyndromes, but the most prevalent and incident individual symptoms were 
similar to our study.28
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impact for Dementia care anD management in general practices
Worldwide, the numbers of people with dementia will increase in the next decades.29 In the 
Netherlands, most people with dementia (70 %) live in the community and are cared for by 
their GP.30,31 The GP has an important role in detecting dementia and disclose the diagnosis 
to the patient and the informal caregivers. The GP is also most often the first physician 
consulted for dementia related problems like NPS and psychological distress in the informal 
caregivers.
We found that NPS are very common in people dementia in primary care. Moreover, people 
with dementia develop new NPS and some of these symptoms appear to be persistent. NPS 
of people with dementia are associated with higher levels of psychological distress in their 
informal caregivers. We also found that psychotropic drug use in primary care is much lower 
than in LTCF (63 - 75 %), although still 53 % of the people with dementia use at least one 
psychotropic drug, including anti-dementia medication.32-34 However, use of anti-dementia 
medication in LTCF is much lower (1 - 14 %) than in our study (34 %).32-34
GPs should be aware that NPS are very common in people with dementia and should 
proactively identify NPS in people with dementia and psychological distress in their infor-
mal caregivers in order to coordinate and facilitate adequate professional care. In addi-
tion, psychotropic drugs should be appropriately prescribed. Medication reviews provide 
a possible strategy to achieve this and reduce psychotropic drug use in LTCF as well as in 
primary care.35,36 The subsyndromes of NPS can facilitate the GP in the detection, analysis 
and management of NPS in people with dementia in primary care.
The Dutch GP guideline for dementia recommends to identify the care needs of people 
with dementia and their informal caregivers, to give information and psycho-education 
and to create a care plan after the diagnosis of dementia. The guideline also provides com-
mon directions for non-pharmacological (psycho-education, individual coaching, cognitive 
behaviour therapy, physical activity, occupational therapy and day care services) as well as 
for pharmacological interventions in case of NPS occur in people with dementia. For NPS 
that cannot be overcome with non-pharmacological or psychosocial interventions it is rec-
ommended to refer to specialists in dementia care, for example the elderly care physician 
and/or geropsychologist.
According to the Dutch Elderly Care Physician guidelines for NPS in dementia it is 
recommended to methodologically and multidisciplinary analyze NPS and to use validated 
assessment instruments like the NPI and CMAI.37 As well as, to actively assess psychological 
distress in informal caregivers related to the NPS. Carrying capacity and competencies of 
the informal caregiver, and environmental characteristics are factors that offer good clues 
for interventions.38 There is limited evidence for the effectiveness of psychotropic drug use 
in case of NPS and particular attention should be paid to possible adverse effects.39,40 The 
prescription of psychotropic drugs is only indicated when non-pharmacological interven-
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tions are not effective and symptoms are severe: antidepressants in case of depression, 
anxiolytics in case of anxiety, antipsychotics in case of severe hallucinations or delusions and 
in case of agitation or aggression and melatonin or trazodone in case of nighttime behaviour 
disturbance.37 This guideline is not yet widely implemented in primary care, but provides 
concrete directions for detecting, analyzing and managing NPS and psychological distress 
as well as for appropriately prescribing psychotropic drugs. In our opinion, cooperation 
between specialists in elderly care, like elderly care physicians, and GPs is most indicated in 
the management of NPS and the prescription of psychotropic drugs.
The coordination of dementia care in general practices is a very important point to consider. 
Many GPs are supported by practice nurses in their general practices. They help the GPs with 
case finding of frail elderly, such as people with dementia and detecting the consequences 
of dementia, and proactive care planning in daily practice. Other health care workers and 
social care professionals are also often involved in the care for people with dementia, like 
case managers, home care services, facilities for respite care or transfer nurses involved in 
waiting list management. Dementia care in primary care can therefore be highly fragmented 
and people with dementia and their informal caregivers sometimes have to deal with many 
different care professionals, irrespective of the legal frameworks for the organization and 
financing of their dementia care.31 This is an important argument for an active role of the 
GP who often has a longstanding relationship with these people with dementia and their in-
formal caregivers. We consider the GP as the ideally situated professional to be the primary 
contact for them. Practice nurses could also play an important role in this process.
In the ideal collaborative dementia care program in primary care timely delivering the 
appropriate and right combination of components after diagnosis and disclosure of diag-
nosis (psychosocial interventions, appropriate prescription of psychotropic drugs, case 
management and coordination and advanced care planning) to the dementia patient and 
informal caregiver is crucial. This will require a stepped-care approach where the intensity 
of care varies according to the level of patient disability.41
To determine the content of (multidisciplinary) care and coordination for people with 
dementia in a general practice the stepped care model provides 3 different modules: level 
1: for people with dementia who are well-functioning; level 2: people with dementia with 
functional impairment, but stable situation; level 3: people with dementia with significant 
functional impairment in a complex setting. In level 1, the GP or practice nurse monitors the 
people with dementia and visits them yearly. Telephone consultations in between the yearly 
visits could also play a role. In level 2, the practice nurse functions as a case manager, an 
individual care plan is set up and the elderly care physician is present at the multidisciplinary 
meetings together with the GP. In level 3, the elderly care physician takes responsibility for 
the individual care plan, the GP remains the primary practitioner and the primary contact 
with the person with dementia and their informal caregivers.
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recommenDations for eDucation
In the last few decades GPs have become more aware of people with dementia and their 
knowledge of dementia has increased. Although timely diagnosis and disclosure of the diag-
nosis in general practices can still improve, the time has come to make GPs more aware of 
the consequences of dementia for the people themselves and for their informal caregivers. 
To increase the awareness of NPS in people with dementia and psychological distress in their 
informal caregivers in GPs and their practice nurses, educational courses should be provided 
nationwide. GPs and their practice nurses should also be given concrete directions for de-
tecting, analyzing and managing NPS and psychological distress as well as for appropriately 
prescribing psychotropic drugs. The use of validated assessment instruments to detect NPS, 
like the NPI and CMAI could be helpful in this process. NPS will often not spontaneously be 
mentioned by the people with dementia and their informal caregivers and possibly even de-
nied. A proactive approach is necessary to detect NPS and psychological distress. In order to 
be able to appropriately prescribe psychotropic drugs GPs and their practice nurses should 
have knowledge on possible non-pharmacological or psychosocial interventions.
recommenDations for future research
The first recommendation for future research would be to investigate the effectiveness of 
a collaborative stepped-care approach for dementia care in general practices taking into 
account the intensity of the care needed for people with dementia and their informal care-
givers. Based on the complexity of the situation (the level of NPS and psychological distress), 
the functional impairment and the patient and caregiver needs, the multidisciplinary team 
could operate in a periodic consultancy model, ongoing co-management mode or as the 
main care provider. Outcome measures that are person- and goal-centered (patient reported 
outcome measures) should be used to effectively measure the effectiveness of such an inter-
vention.42 Also aspects like personality, coping and mutual relationship should be chosen to 
get more insight into the factors that have association with the outcome measures on NPS 
and psychological distress.43,44 Such an intervention should be unrolled nationwide in order 
to achieve a good sample size and encourage unambiguous dementia care and management 
in all general practices.
The second recommendation is a trial for appropriate psychotropic drug use in people 
with dementia in primary care following the example of a similar study in Dutch nursing 
homes.36,45 In a pilot study the proportion of inappropriate psychotropic drug use in people 
with dementia in primary care should be determined. The consecutive intervention should 
consist of a structured and repeated biannual medication review, preferably multidisciplinary 
by a pharmacist, GP, elderly care physician and practice nurse. The main goal of such a study 
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would be to improve the proportion of people with dementia with appropriate psychotropic 
drug use.
Finally, the implementation of the 2 described recommendations for future research 
should be conducted conform the Consolidated Framework for Implementation Research 
(CFIR) in order to be able to effectively realize these interventions.46
concluDing remarks
In conclusion, this thesis adds important knowledge about the occurrence of NPS and psy-
chotropic drug use and the course of NPS in people with dementia in primary care and about 
psychological distress in their informal caregivers.
• NPS are very common in people with dementia in general practice. Over a period of 
18 months several NPS are highly prevalent, incident and persistent, especially in the 
hyperactivity and mood/apathy subsyndrome. The most common clinically relevant 
individual NPS are aberrant motor behaviour, agitation/aggression and apathy.
• Fifty-three percent of the people with dementia used at least one psychotropic drug, 
14 % use at least two different and 4 % use at least three psychotropic drugs, includ-
ing anti-dementia medication. Excluding anti-dementia medication, almost 29 % of 
the patients use at least one, 7 % use at least two different and 2 % use at least three 
psychotropic drugs.
• Informal caregivers of people with dementia in primary care have a high risk for 
depression and are likely to have mental problems. Female informal caregivers, informal 
caregivers aged 50 - 70 years and being a spouse is associated with higher levels of 
psychological distress.
GPs or their supporting practice nurses should be aware of this and should actively identify 
NPS in people with dementia and psychological distress in their informal caregivers in order 
to coordinate and facilitate adequate professional care.
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english summary
Most people with dementia live in the community and are cared for by their general 
practitioner (GP). The GP is most often the first physician consulted for dementia related 
problems. During the course of dementia most people develop some type of behavioural 
symptoms, also called neuropsychiatric symptoms (NPS). Psychotropic drugs are often 
prescribed in this process, which can cause serious adverse effects. NPS are associated 
with psychological distress in informal caregivers. Almost all studies on the course of NPS 
in community-dwelling people with dementia were conducted in ambulatory patients with 
dementia visiting outpatients’ memory, (old-age) psychiatry, neurological or geriatric clinical 
centres or dementia services. Only a limited proportion of people in general practice in the 
Netherlands are referred to secondary care. Therefore, it is likely that a study population 
visiting outpatient clinical centres has more severe and frequent symptoms than the total 
group of people with dementia in general practice. For GPs, it is important that accurate 
data of NPS and psychotropic drug use of patients with dementia in general practices are 
available in order to enlarge their awareness and initiate timely and adequate professional 
care. Therefore, the general aim of this thesis is to investigate the prevalence of NPS and psy-
chotropic drug use, as well as the course and determinants of NPS in people with dementia 
and the psychological distress in their informal caregivers in primary care. In chapter 1 the 
background for the aims and research questions of this thesis are further addressed.
In chapter 2 we describe the design of our prospective naturalistic observational cohort 
study with a follow-up of 18 months. Thirty-seven GPs in 18 general practices in the southern 
part of the Netherlands participated in this study. In the electronic medical files of these 
practices we identified and recruited 117 dyads of patients with a diagnosis of dementia 
and their informal caregivers. Dyads were assessed at baseline and after 9 and 18 months. 
Follow-up was continued after admission to a nursing home. In 14 of the participating 
general practices, a multicomponent collaborative care program named CONCERN (Care Op-
timization for Non-professional Caregivers of Elderly with dementia and Reduction of Neuro-
psychiatric symptoms) was provided. In this care program the GP, elderly care physician and 
a dementia case manager focus on optimization of care for people with dementia and their 
informal caregivers. The primary outcome measures of this study are the Neuropsychiatric 
Inventory (NPI) score for the NPS and Sense of Competence (SCQ) score for psychological 
distress in the informal caregivers.
In chapter 3 existing literature is reviewed to get more insight into the course of community-
dwelling people with dementia. Previous research indicates that NPS in general are highly 
prevalent, incident and persistent although the results of the studies varied considerably. 
The difference in results between studies may partly be explained by the different assess-
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ment instruments used, the different intervals between assessments and different follow-up 
periods. Former research shows that virtually all patients with dementia show NPS during 
a period of 1 - 6 years. NPS in the affective subgroup are the most prevalent, NPS in the 
psychotic subgroup the least prevalent. Delusions, wandering/agitation, aberrant motor 
behaviour/motor hyperactivity, and apathy are the most common individual NPS. The most 
common NPS in community-dwelling people with dementia are also the most common 
symptoms in people with dementia in nursing homes, especially wandering/agitation and 
apathy.
chapter 4 reports on the prevalence of NPS and psychotropic drug use at baseline. NPS were 
very common in people with dementia in general practice: 66 % had at least one clinically 
relevant NPS (NPI score ≥ 4). The most common clinically relevant NPS were aberrant motor 
behaviour, agitation/aggression and apathy. Fifty-three percent of the people with dementia 
use psychotropic medication including anti-dementia medication. Excluding anti-dementia 
medication, almost 29 % of the patients used at least one, 7 % used at least two different 
and 2 % used at least three psychotropic drugs. Antipsychotics were prescribed to 10 %, 
antidepressants to 17 % and anti-dementia medication to 34 % of the patients.
In chapter 5 the results for the course of NPS over 18 months are presented. Several NPS 
were highly prevalent, incident and persistent and some NPS were more likely to resolve. 
The majority of people with dementia showed one or more symptoms of the mood/apathy 
or the hyperactivity subsyndrome (72 % versus 75 %) over the follow-up period. For people 
with dementia with one or more symptoms at baseline, these persisted in 20 % and 25 %, 
respectively. Approximately half of the patients with dementia without symptoms of the 
mood/apathy or hyperactivity subsyndrome at baseline developed these at subsequent 
measurements (48 % versus 55 %). The clinically relevant symptoms aberrant motor behav-
iour, apathy and in a slightly lesser degree agitation/aggression occurred frequently in a 
period of 18 months (59 %, 51 % and 46 %). Apathy and agitation/aggression were the most 
persistent symptoms. On the other hand, most patients with dementia remained free of 
symptoms of the psychosis subsyndrome. Concerning the agitated/aggressive symptoms, 
the verbally agitated symptoms were the most prevalent over the follow-up period, closely 
followed by physically non-aggressive symptoms (88 % versus 83 %). These symptoms were 
also very likely to occur after baseline (cumulative incidence 64 % versus 58 %) and to persist 
over the follow-up period (48 % versus 69 %). We did not find clinically relevant associations 
between the independent variables at baseline (patients’ age, gender, cognition, psycho-
tropic drug use and use of respite care or personal health care, and informal caregivers’ 
psychological distress, as well as participation in CONCERN) and the course of NPS over time.
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chapter 6 reports on the results for the course of psychological distress of the informal care-
givers. At baseline, 23 % of informal caregivers of people with dementia in primary care had 
a high risk for depression (CES-D) and 41 % were identified to be likely to have psychological 
symptoms (GHQ-12). The total group of these informal caregivers showed a stable pattern 
of psychological distress (SCQ). Higher frequency of NPS as well as informal caregivers’ age, 
gender and relationship to the patient were associated with higher psychological distress. 
Female informal caregivers, informal caregivers aged 50 - 70 years and being a spouse were 
associated with higher levels of psychological distress. The psychological distress of the 
informal caregivers improved when the patient they cared for was admitted to a LTCF during 
the study. We did not find associations between the independent variables at baseline 
(caregivers’ age and gender, patient-caregiver relationship, patients’ cognition and NPS, as 
well as participation in CONCERN and admission to a LTCF) and the course of psychological 
distress over time.
Finally, in chapter 7 we provide an overview of our main findings in this thesis and we 
reflect on our methodological choices. In addition, implications for dementia care in general 
practices, as well as recommendations for future research are discussed. We conclude that 
GPS should be aware of the occurrence of NPS in people with dementia and psychological 
distress in their informal caregivers and actively identify these in order to coordinate and 
facilitate adequate professional care.
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De meeste mensen met dementie wonen thuis en worden begeleid door hun huisarts. De 
huisarts is meestal de eerste persoon, die geconsulteerd wordt bij aan dementie gerelateerde 
problemen. Tijdens het beloop van dementie ontwikkelen de meeste mensen een vorm van 
probleemgedrag, die ook wel neuropsychiatrische symptomen (NPS) worden genoemd. Vaak 
worden hierbij psychofarmaca voorgeschreven, die ernstige bijwerkingen kunnen geven. NPS 
zijn ook van invloed op de ervaren psychologische belasting bij mantelzorgers. Bijna alle on-
derzoeken naar het beloop van NPS bij thuiswonende mensen met dementie zijn uitgevoerd 
bij ambulante patiënten met dementie van geheugenpoli’s, (ouderen)psychiatrische, neuro-
logische of geriatrische klinische centra of andere gespecialiseerde centra voor dementie. In 
Nederland wordt slechts een klein gedeelte van de patiënten uit een huisartspraktijk door-
verwezen naar deze gespecialiseerde centra in de tweede lijn. Het is daarom aannemelijk, 
dat een onderzoekspopulatie van mensen vanuit klinische centra symptomen hebben, die 
ernstiger zijn en vaker voorkomen dan in de totale groep van mensen met dementie in de 
huisartspraktijk. Voor huisartsen is het belangrijk, dat er nauwkeurige gegevens beschikbaar 
zijn over NPS en het gebruik van psychofarmaca binnen de huisartspraktijk om de bewust-
wording hiervan te vergroten en om op tijd adequate zorg in te kunnen zetten. Daarom is 
het doel van dit onderzoek om binnen de huisartspraktijk de aanwezigheid van NPS en psy-
chofarmacagebruik bij mensen met dementie vast te stellen. En daarnaast om het beloop en 
de beïnvloedende factoren van NPS bij mensen met dementie en die van de psychologische 
belasting van hun mantelzorgers te onderzoeken. In hoofdstuk 1 wordt verder ingegaan op 
de achtergrond van de doelstellingen en onderzoeksvragen van dit proefschrift.
In hoofdstuk 2 wordt de onderzoeksopzet van onze prospectieve, naturalistische, observationele 
cohortstudie beschreven. Het onderzoek duurde 18 maanden en er namen 37 huisartsen uit 18 
verschillende huisartspraktijken aan deel. In de elektronische medische dossiers van deze huisarts-
praktijken werden patiënten met dementie en hun mantelzorgers geselecteerd, waarvan er 117 
wilden deelnemen aan dit onderzoek. Gegevens van deze patiënten met dementie en gegevens 
van hun mantelzorgers werden verzameld bij het starten van het onderzoek en na 9 en 18 maan-
den. Ook wanneer patiënten met dementie werden opgenomen in een zorginstelling werden zij en 
hun mantelzorgers verder vervolgd in dit onderzoek. In 14 van de deelnemende huisartspraktijken 
konden de geselecteerde patiënten en hun mantelzorgers eventueel deelnemen aan een zorgpro-
gramma genaamd CONCERN (Care Optimization for Non-professional Caregivers of Elderly with 
dementia and Reduction of Neuropsychiatric symptoms). In dit zorgprogramma werken huisarts, 
specialist ouderengeneeskunde en een casemanager dementie samen om de zorg voor mensen 
met dementie en hun mantelzorgers te verbeteren. De belangrijkste vragenlijsten die gebruikt 
worden in dit onderzoek, zijn de Neuropsychiatrische vragenlijst (NPI) score voor NPS en de Sense 
of Competence Questionnaire (SCQ) score voor psychologische belasting bij de mantelzorgers.
appendix
158
In hoofdstuk 3 wordt de bestaande literatuur beoordeeld en besproken om meer inzicht te 
krijgen in het beloop van NPS bij thuiswonende mensen met dementie in eerder verricht 
onderzoek. Eerder onderzoek geeft aan dat NPS in het algemeen heel vaak voorkomen, vaak 
nieuw ontstaan en blijven bestaan, alhoewel de resultaten van de verschillende onderzoe-
ken sterk uiteenlopen. De verschillen in resultaten tussen de onderzochte studies kunnen 
gedeeltelijk worden verklaard door het gebruik van verschillende meetinstrumenten, de 
verschillende tijdsintervallen tussen de momenten waarop de gegevens werden verzameld 
en de verschillende lengten van studieduur. In eerder onderzoek lieten vrijwel alle mensen 
met dementie NPS zien tijdens een studieduur van 1 tot 6 jaar. Affectieve symptomen komen 
het meest voor en psychotische symptomen komen het minst vaak voor. Wanen, dwalen/
agitatie, afwijkend motorisch gedrag/motorische hyperactiviteit en apathie zijn de meest 
voorkomende individuele NPS. De meest voorkomende NPS bij thuiswonende mensen met 
dementie komen overeen met de meest voorkomende NPS bij mensen met dementie in 
zorginstellingen. Dit geldt met name voor dwalen/agitatie en apathie.
hoofdstuk 4 beschrijft de resultaten van het uitgevoerde onderzoek in de huisartspraktijk 
naar de aanwezigheid van NPS en het gebruik van psychofarmaca bij het eerste meetmoment 
van het onderzoek. NPS komen vaak voor bij mensen met dementie in de huisartspraktijk: 
66 % had ten minste één klinisch relevant symptoom (NPI score ≥ 4). De meest voorkomende 
klinisch relevante NPS zijn: doelloos repetitief gedrag, agitatie/agressie en apathie. Van de 
mensen met dementie gebruikt 53 % psychofarmaca inclusief medicijnen tegen dementie. 
Wanneer medicijnen tegen dementie niet worden meegerekend dan gebruikt bijna 29 % 
van de patiënten ten minste één, 7 % ten minste twee en 2 % ten minste drie verschillende 
psychofarmaca. Antipsychotica worden voorgeschreven bij 10 %, antidepressiva bij 17 % en 
medicijnen tegen dementie bij 34 % van de mensen met dementie.
In hoofdstuk 5 worden de resultaten gepresenteerd over het beloop van NPS tijdens de 18 
maanden van het onderzoek in de huisartspraktijk. Meerdere NPS kwamen veel voor, ont-
stonden nieuw of bleven bestaan en sommige NPS verdwenen vaker. In het onderzoek zijn 
NPS onderverdeeld in subgroepen. Het merendeel van de mensen met dementie liet één of 
meer symptomen zien in de subgroep stemming/apathie en in de subgroep hyperactiviteit 
(72 % versus 75 %) tijdens het onderzoek. Bij mensen met dementie met één of meer symp-
tomen bij het eerste meetmoment van het onderzoek, bleven deze bij 20 % tot 25 % van 
de mensen met dementie tijdens de gehele duur van het onderzoek bestaan. Ongeveer de 
helft van de mensen met dementie, die geen symptomen hadden in de subgroep stemming/
apathie en hyperactiviteit bij het eerste meetmoment van het onderzoek, vertoonden deze 
symptomen wel bij één van de volgende meetmomenten (48 % versus 55 %). De klinisch 
relevante symptomen doelloos repetitief gedrag, apathie en in iets mindere mate agitatie/
agressie kwamen vaak voor tijdens de 18 maanden (59 %, 51 % en 46 %) van het onderzoek. 
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Apathie en agitatie/agressie waren de symptomen, die het meest frequent bleven bestaan. 
Veel mensen met dementie hadden geen symptomen uit de subgroep psychose. Wanneer 
deze symptomen van agitatie/agressie nader worden bekeken, dan blijkt dat de subgroep 
met verbaal geagiteerde symptomen het meest voorkomt tijdens de duur van het onderzoek, 
evenals de subgroep met fysiek niet-agressieve symptomen (88 % versus 83 %). Deze sympto-
men ontstonden ook vaak voor het eerst na de start van het onderzoek (64 % versus 58 %) of 
bleven bestaan tijdens de duur van het onderzoek (48 versus 69 %). Er is geen klinisch relevant 
verband gevonden tussen de onafhankelijke variabelen bij de start van het onderzoek (leef-
tijd, geslacht en cognitie van de patiënt, gebruik van psychofarmaca, gebruik van respijtzorg 
of persoonlijke verzorging van de patiënt, psychologische belasting van de mantelzorgers en 
deelname aan het zorgprogramma CONCERN) en het beloop van NPS in de tijd.
hoofdstuk 6 beschrijft de resultaten naar het beloop van psychologische belasting bij de 
mantelzorgers in de huisartsenpraktijk. Bij de start van het onderzoek hadden 23 % van de 
mantelzorgers van mensen met dementie een hoog risico op depressie (gemeten met de 
CES-D) en bij 41 % van hen was het waarschijnlijk, dat ze psychologische symptomen hadden 
volgens de GHQ-12. De totale groep van mantelzorgers liet een stabiel niveau zien van 
psychologische belasting tijdens het onderzoek (SCQ). Er is een verband tussen de mate van 
NPS bij de patiënt en de ervaren psychologische belasting bij de mantelzorger. Er is ook een 
verband tussen de leeftijd en het geslacht van de mantelzorger en de relatie met de patiënt 
en de mate van ervaren psychologische belasting. Vrouwelijke mantelzorgers, mantelzorgers 
in de leeftijd van 50 tot 70 jaar en echtgenoten/partners ervaren meer psychologische 
belasting. De ervaren psychologische belasting nam af, wanneer de patiënt waar zij zorg 
voor droegen werd opgenomen in een zorginstelling tijdens het onderzoek. Er is geen 
klinisch relevant verband gevonden tussen de onafhankelijke variabelen bij de start van het 
onderzoek (leeftijd en geslacht van de mantelzorger, relatie tussen patiënt en mantelzorger, 
cognitie en NPS bij de patiënt deelname aan het zorgprogramma CONCERN en opname in 
een zorginstelling) en het beloop van psychologische belasting bij de mantelzorgers in de tijd.
Ten slotte wordt in hoofdstuk 7 een overzicht gegeven van de belangrijkste bevindingen uit 
dit proefschrift en is er een beschouwing opgenomen over de gekozen methodologie. De 
consequenties van deze bevindingen voor de zorg voor mensen met dementie en hun man-
telzorgers in de huisartspraktijk worden bediscussieerd en aanbevelingen voor toekomstig 
onderzoek worden gedaan. De eindconclusies zijn, dat huisartsen alert moeten zijn op de 
aanwezigheid van NPS bij mensen met dementie en op de psychologische belasting hiervan 
bij de mantelzorgers. En dat huisartsen NPS en psychologische belasting bij de mantelzorgers 
actief moeten opsporen om op tijd adequate professionele zorg te kunnen inzetten.

161
Abbreviations
abbreviations
aCheI acetylcholinesterase inhibitor
AD Alzheimer’s disease
(i)ADL (instrumental) activities of daily living
CES-D Center for Epidemiological Studies Depression Scale
CI confidence interval
CM case manager
CMAI Cohen-Mansfield Agitation Inventory
CMO  Committee on Research Involving Human Subjects  
(Commissie Mensgebonden Onderzoek)
CONCERN  Care Optimization for Non-professional Caregivers of Elderly with dementia 
and Reduction of Neuropsychiatric symptoms
CSDD Cornell scale for depression in dementia
DelpHi-MV  Dementia life- and person-centered help in Mecklenburg - Western Pomerania
Dyad patient and caregiver
GHQ General Health Questionnaire
GP(s) general practitioner(s)
LASER-AD London And the South East Region – Alzheimer’s Disease
LBD dementia with Lewy bodies
LTCF long-term care facilities
MAASBED MAAstricht Study of BEhaviour in Dementia
MMSE Mini-Mental State Examination
n number of participants
NMDAR N-methyl-d-aspartate receptor antagonist
NPI(-Q) Neuropsychiatric Inventory (- Questionnaire)
NPS neuropsychiatric symptoms
p calculated probability
PPA patients per assessment
rCT randomized controlled trial
REAL.FR Réseau sur la Maladie d’Alzheimer Français
SCQ Sense of Competence Questionnaire
SD standard deviation
SSRIs  selective serotonin re-uptake inhibitors or serotonin-specific reuptake 
inhibitors
VaD vascular dementia
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andere kant bekeken. Het congres van de International Psychogeriatric Association (IPA) in 
Cairns in Australië was daarbij een echt hoogtepunt.
Peter, jij was mijn rots in de branding, zoals je naam ook al zegt. Altijd rustig en relative-
rend. “Wat heb ik hier als huisarts in de spreekkamer nu eigenlijk aan?” Bedankt voor al je 
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feedback op en hulp bij mijn stukken om deze methodologisch en ook taalkundig in goede 
banen te leiden. Het is er altijd veel beter van geworden.
Hans, bescheiden en behulpzaam, zelfs nadat je al met pensioen was. Bedankt voor je 
geduld om keer op keer opnieuw de statistische analyses met mij door te nemen en uit te 
voeren.
Anne Margriet, je kritische blik en inbreng uit onverwachte invalshoeken hebben mij 
steeds weer verder op weg geholpen tijdens het schrijven van alle publicaties. Door je werk 
in het buitenland was je aanwezigheid bij de bijeenkomsten de laatste jaren, ondanks skype, 
minder vaak dan je had gewild, maar dat is je vergeven.
Roland, ook jij bedankt voor je inhoudelijke input aan de begeleidingscommissie en de 
artikelen. Hoe was het ook al weer: promoveren is 10 % inspiratie en 90 % transpiratie. Ik 
denk, dat het aardig klopt.
De leden van de manuscriptcommissie: prof. dr. R.P.C. Kessels, prof. dr. M.J.L. Graff en prof. 
dr. J.W.M. Muris, ben ik zeer erkentelijk voor het lezen en beoordelen van mijn manuscript.
Daarnaast zijn er vele lieve collega’s, vrienden en familie, die mij in de afgelopen jaren 
persoonlijk hebben gesteund of in ieder geval belangstellend zijn blijven informeren hoe de 
stand van zaken was. Een aantal daarvan wil ik graag persoonlijk bij naam noemen.
Op het Radboudumc wil ik in het bijzonder Annelies Daanen even noemen. Steun en 
toeverlaat voor mij en de andere onderzoekers. Altijd tijd voor een praatje en altijd bereid 
om iets te regelen of ergens bij te ondersteunen. Annelies, geniet van je pensioen! Andere 
collega’s en onderzoekers op het Radboudumc, die ik in de afgelopen jaren regelmatig of 
minder vaak ontmoette, wanneer ik weer eens in Nijmegen was: Anke, Anne, Annelies, 
Annemiek, Arjanne, Brenda, Britt, Charlotte, Christian, Claudia, Debby, Deborah, Els, Erica, 
Erik, Jan, Jeannette, Klaas, Roeslan en Willemijn. Bedankt voor de gezelligheid in Nijmegen 
en daarbuiten bij de (buitenlandse) congressen.
Collega’s van de vakgroep bij Thebe Zuid-Oost in Goirle: Anita, Anneke, Ans, Arno, Els, 
Inga, Jaap, Maas, Mira, Odile en Sabine. Lieve Odile en Ans, samen hebben we de kar getrok-
ken voor de vakgroep. Ook deelde ik de belangstelling voor het wetenschappelijk onderzoek 
met jullie, evenals de broodnodige melkchocola met karamel en zeezout!
Sylvia van ’t Heem. De klik tussen ons was zo goed, dat we altijd contact hebben gehou-
den. En jij en Jan hebben wel het vaakst belangstellend en hoopvol gevraagd: “of ik nu toch 
echt bijna klaar was?” Wanneer gaan we weer uit eten?!
Collega’s van Laurens Antonius Binnenweg: Cobie, Elianne, Elisabeth, Godert, Hanneke, 
Herbert, Inge, Jan, Karina, Lotte, Manila, Manju, Marco, Marieke, Marlies, Patricia, Romke, 
Summera en Wilma. Bedankt voor de samenwerking en de mogelijkheden, die ik ook van 
jullie heb gekregen om aan mijn onderzoek te werken! Ik koester mijn herinneringen aan 
jullie, het fijnste artsenteam waar ik ooit mee samen heb gewerkt.
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Dankwoord
Miranda, Mirjam, Amy en Tessa, maar zeker ook alle andere zorgmedewerkers van de 
Jacobahof Zorgvilla in Oostvoorne. Mooi om met jullie samen in de praktijk kwalitatief 
goede zorg te kunnen bieden aan jullie kwetsbare bewoners, samen met de familie en de 
huisartsen. En dank voor jullie medeleven, blijdschap en felicitaties, wanneer er weer een 
publicatie was geaccepteerd.
De maten van Gericare, en in het bijzonder Coert, Karla, As’ad, Adriaan, Vincent en Sarja. 
En natuurlijk Saskia! Ieder van ons is aan het pionieren in de eerste lijn en we delen onze 
ervaringen. Veel dank, dat ik bij jullie aan mocht sluiten voor de financiering bij het zorgkan-
toor, zodat ook ik nu mijn samenwerking met verschillende huisartspraktijken inhoudelijk 
vorm kan geven en continuïteit kan bieden.
(Oud-)collega’s van de Kaderopleidings Pychogeriatrie bij GERION: Dick, Carola, Jacobien, 
Jos, Michelle en Karin, maar ook Harriët, Henk en Martin. Het is heerlijk is het om op hoog 
niveau samen te mogen werken aan onderwijs over psychogeriatrie voor specialisten oude-
rengeneeskunde!
Leden van de intervisiegroep KaderPraatGroep: Ashrat, Dianne, Hille, Jolanda, Marc, 
Maryon, Norbert, Peter en Wilma. Wij delen vanaf 2014 de moeilijke casuïstiek en ethische 
dilemma’s in ons dagelijks werk, daar waar het echt om gaat en wat ons persoonlijk raakt.
Cisca Kieftenburg, collega van het eerste uur van De Plantage in Brielle, trouw en gezellig. 
Fijn, dat we altijd contact hebben gehouden. We moeten een andere manier vinden om bij 
te kletsen, nu er een einde gaat komen aan de ritten naar Nijmegen.
Mijn schoonouders, Arjen en Gerda. “Het leven is wat je overkomt, als je andere plannen 
maakt.” Dat hebben jullie recent helaas aan den lijve ondervonden. Jullie zijn er nog! En daar 
zijn we intens dankbaar voor.
Eefke, Ingrid, Martine en Miranda van “onze” meidengroep. Sinds we elkaar in 1991 
ontmoet hebben in de collegebanken tijdens onze studie geneeskunde aan de Erasmus 
Universiteit in Rotterdam, hebben we lief en leed en veel mooie momenten met elkaar ge-
deeld. Het is heerlijk om een vriendinnengroep te hebben, die zo vertrouwd is en te genieten 
van met elkaar uit eten gaan en onze meidenweekenden te beleven. Lieve Miranda, vorig 
jaar mocht ik als paranimf bij jouw promotie aan je zijde staan. Nu doe je dat voor mij. Jij 
weet als geen ander, hoe het is om een promotietraject tot een goed einde te brengen, 
als echtgenote, moeder, collega en vriendin. Het is ons allebei gelukt. Ik hoop, dat je nu 
ontspannen mee kunt genieten van mijn dag.
Sandra en Frank, onze allerbeste vrienden, jullie liggen ons heel na aan het hart. Onze ge-
zamenlijke “bourgondische week” in de voorjaarsvakantie is altijd een van de hoogtepunten 
van het jaar. Daarbuiten zien we elkaar gelukkig ook regelmatig en delen we alle bijzondere 
momenten. Wij zijn ook dankbaar voor en genieten van jullie liefde en aandacht voor Anne 
en Thijs. Lieve Sandra, zo’n 26 jaar geleden kwamen we als vanzelfsprekend in hetzelfde 
tentje terecht tijdens onze 1e wandelvakantie in de Franse Pyreneeën. En onze vriendschap 
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is daarna vanzelfsprekend ontstaan, gegroeid en gebleven. Ik kan altijd alles met je delen, je 
bent me heel dierbaar!
Lieve pa en ma, jullie hebben Bert en mij een fijne en onbezorgde jeugd gegeven en alle 
mogelijkheden om ons op verschillende gebieden te ontwikkelen. Jullie hebben mij altijd 
gestimuleerd en gesteund, welke weg ik ook koos, en altijd geholpen om mijn doelen te 
bereiken. Jullie waren en zijn er altijd voor mij en ik hoop dat jullie nog lang in mijn leven 
mogen blijven. We genieten erg van de verre reizen, die we samen maken. Prachtige herin-
neringen, die ik altijd zal koesteren.
Lieve Anne en Thijs, jullie ondervinden als pubers aan den lijve, hoe ingewikkeld het brein 
is met alle veranderingen daarin. Jullie zijn heel goed op weg op jullie eigen levensreis om 
prachtige mensen te worden en jullie eigen weg in het leven te zoeken en te vinden. Ik ben 
ongelofelijk trots op hoe jullie je in de afgelopen jaren ontwikkeld hebben en nog aan het 
ontwikkelen zijn. Ik hou heel veel van jullie!
Mijn allerliefste Sebastiaan, jij bent het beste wat me in mijn leven is overkomen. Jouw 
liefde en zorgzaamheid zijn grenzeloos. Het is alweer ruim 21 jaar geleden, dat we samen op 
avontuur zijn gegaan en we hebben steeds in overleg samen de weg uitgestippeld. Je hebt 
me daarbij altijd heel veel ruimte en volledig vertrouwen gegeven. Ook dit promotietraject 
was een bewuste gezamenlijke keuze. Ik ben je er heel dankbaar voor en het heeft ons, 
naast veel inzet van ons beiden, gelukkig ook veel goeds gebracht. Nu is er ook weer ruimte 
voor jouw persoonlijke ontwikkeling. Ik hoop, dat we nog heel lang samen kunnen groeien 
en ontwikkelen, maar vooral ook kunnen genieten van elkaar en van iedereen die ons lief is.
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